rfhg_146438.1

Basic information about the TSS

---

TSS ID: rfhg_146438.1 Species: human Chr: chr12		Start: 6770763 End: 6770771 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: DQ894125:-370 GeneID: 5763 HGNC/MGI_ID: HGNC:9629 UniProt_ID: Nearer transcript ids and distances:

Gene_name: parathymosin Gene_symbol: PTMS Gene_synonyms: ParaT Gene_source: HGNC:9629

TATA-Box annotation

---

Distance to TSS:	-1753
Nearest PromoterID:	NM_002286
Entrez ID:	3902
Nearest Unigene:	Hs.409523
Nearest Refseq:	NM_002286
Nearest Ensembl:	ENSG00000089692
Gene Name:	parathymosin
Gene Alias:	CD223
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.555556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PTMS p2@PTMS p3@PTMS p4@PTMS p5@PTMS p6@PTMS p7@PTMS p8@PTMS p9@PTMS p10@PTMS
Sample		p1@PTMS	p2@PTMS	p3@PTMS	p4@PTMS	p5@PTMS	p6@PTMS	p7@PTMS	p8@PTMS	p9@PTMS	p10@PTMS
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	287.92	34.48	1.56	18.12	14.42	7.21	3.31	1.36	5.65	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	266.66	33.18	2.63	20.84	17.20	6.47	3.84	1.62	2.63	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	233.03	39.74	2.31	22.76	19.29	9.65	3.09	2.51	2.89	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	224.75	25.16	2.91	16.84	12.06	6.45	4.37	1.87	5.82	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	255.34	30.60	1.80	25.42	11.25	7.65	5.62	0.90	2.47	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	213.39	29.07	2.71	18.61	11.43	8.14	2.71	1.74	1.94	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	202.63	30.94	2.40	33.34	15.25	10.46	2.83	3.70	5.66	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	210.73	27.86	1.70	21.56	15.50	8.72	2.18	2.18	6.54	2.66
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	258.17	30.13	0.85	26.93	10.69	5.56	2.78	2.14	4.49	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	217.94	15.65	1.16	13.33	9.85	4.06	1.74	0.58	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	207.37	11.32	0.81	16.17	9.70	4.85	0.81	0.40	2.83	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	192.30	8.94	1.22	16.67	6.10	3.25	1.22	1.22	2.85	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	270.00	17.41	10.48	1.61	18.21	12.73	5.96	0.97	0.64	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	192.90	18.04	11.28	1.80	13.53	7.52	4.66	0.75	0.30	3.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	253.36	16.25	9.44	1.76	12.95	7.68	6.37	0.22	0.44	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	239.92	17.10	9.31	1.01	23.39	12.57	5.03	2.01	0.75	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	215.79	18.13	10.05	2.62	10.70	9.61	4.59	0.22	1.75	1.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	205.42	16.03	9.28	2.11	25.73	14.76	3.37	0.84	1.27	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	155.68	17.59	8.00	1.07	15.46	4.80	3.73	1.07	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	185.34	13.84	11.88	1.05	14.14	9.48	4.81	1.20	0.30	3.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	219.46	15.50	8.55	3.07	16.57	8.15	4.81	0.67	0.67	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	189.89	15.88	8.46	2.76	16.23	13.46	3.97	0.52	0.52	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	209.53	17.71	10.21	2.97	14.74	7.63	3.23	1.03	0.65	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	235.14	17.71	7.28	4.13	22.08	9.95	4.61	0.24	0.24	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	220.07	18.32	10.58	1.55	21.41	10.06	4.64	1.03	0.52	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	214.60	16.78	8.86	1.58	17.41	8.55	2.85	1.58	0.63	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	167.04	14.29	6.04	3.85	29.12	10.44	3.85	1.10	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	236.70	19.10	11.32	3.06	15.32	7.78	4.24	0.71	1.41	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	172.99	12.92	8.56	1.45	17.12	8.88	5.01	0.81	0.81	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	216.07	14.48	9.05	2.90	17.55	10.13	4.16	1.09	0.90	3.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	195.11	15.49	9.42	1.26	15.07	13.19	5.23	1.05	0.63	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	218.44	15.24	12.11	2.15	21.69	11.72	4.30	0.39	0.78	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	179.59	16.67	9.50	1.69	24.06	22.79	5.49	0.42	0.21	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	148.78	22.43	12.87	3.13	17.81	10.72	2.80	1.65	0.66	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	202.51	17.76	10.47	4.49	15.52	13.28	3.93	1.31	0.75	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	246.43	18.78	10.35	3.64	18.20	9.58	6.52	0.77	0.00	2.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	227.48	18.39	11.85	2.45	22.28	11.45	4.50	1.23	1.02	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	226.87	16.92	8.46	2.62	12.09	11.08	5.44	1.41	1.61	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	247.14	20.53	7.56	3.78	20.80	10.80	6.48	2.70	1.08	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	222.30	16.80	7.68	4.80	16.56	6.48	4.80	2.88	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	220.44	16.70	9.65	2.59	20.70	9.18	4.23	1.65	1.18	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	167.48	21.08	12.15	3.37	15.66	10.69	1.90	1.02	1.32	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	233.67	17.50	6.12	5.06	21.09	11.18	4.01	1.27	1.48	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	248.25	15.91	9.97	2.62	26.40	14.16	6.82	1.05	1.22	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	262.21	15.26	8.03	1.81	14.05	8.83	6.22	1.20	1.00	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	272.43	17.45	9.77	2.09	25.82	12.80	5.35	0.23	0.23	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	249.26	16.07	8.64	2.40	20.15	8.64	5.28	0.48	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	254.24	18.18	10.43	5.07	19.08	9.24	5.07	1.19	1.79	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	301.37	16.28	10.53	5.74	18.43	8.86	7.66	0.96	1.91	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	221.41	14.96	10.31	3.84	16.98	11.32	4.25	1.62	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	249.43	14.35	7.17	3.69	28.90	14.96	5.74	0.82	0.61	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	330.89	14.90	7.12	4.23	27.13	14.23	6.67	1.11	0.67	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	685.62	83.95	55.97	69.96	27.98	0.00	0.00	13.99	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	268.98	18.81	3.90	2.13	18.81	12.42	6.03	1.06	1.42	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	239.59	17.23	5.63	3.31	19.22	7.95	3.65	0.99	1.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	166.95	20.13	21.81	20.97	51.18	19.30	5.03	2.52	0.84	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	172.22	12.86	8.27	5.97	47.76	11.02	2.76	0.46	1.84	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	303.04	16.21	4.86	2.92	29.82	9.08	8.10	0.65	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	343.65	17.02	6.74	5.14	31.47	12.85	7.71	1.28	2.25	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	210.92	8.49	10.69	5.97	42.43	13.52	6.60	1.26	0.94	4.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	255.23	15.51	2.82	3.53	19.74	8.46	4.94	2.82	0.71	4.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	245.63	21.31	2.24	4.49	24.67	8.97	5.61	3.93	0.56	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	452.21	15.13	23.88	9.55	82.00	27.07	11.15	2.39	3.98	9.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	306.13	8.83	9.51	4.08	53.34	19.37	4.42	0.34	0.34	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	418.82	11.37	2.92	4.55	42.56	25.67	6.50	1.30	0.97	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	508.69	13.13	3.90	3.19	47.92	15.62	9.23	0.71	1.77	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	905.18	145.48	129.31	64.66	80.82	0.00	48.49	64.66	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	900.31	118.46	39.49	31.59	15.79	7.90	39.49	7.90	15.79	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	314.94	22.43	1.95	3.41	33.64	14.63	4.88	2.44	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	253.89	18.35	2.98	2.98	24.30	15.87	4.46	1.49	3.47	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	274.43	17.36	3.28	7.51	35.65	8.91	5.16	0.94	0.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	227.20	9.94	4.31	10.27	41.40	9.27	6.62	1.32	2.98	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	226.44	14.85	3.09	5.57	25.98	12.37	5.88	0.93	2.47	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	223.19	20.79	1.53	8.26	19.57	7.34	5.50	0.92	2.14	1.53
Adipocyte - breast, donor1	11376-118A8	395.96	71.43	10.45	14.57	12.04	11.09	6.34	3.33	2.38	3.80
Adipocyte - breast, donor2	11327-117E4	426.90	63.53	10.75	13.64	15.56	23.42	3.69	4.49	2.25	5.13
Adipocyte - omental, donor1	11473-119C6	370.61	77.23	12.47	12.47	11.96	11.45	3.05	5.60	2.54	2.93
Adipocyte - omental, donor2	11474-119C7	423.08	61.29	11.96	13.45	20.93	14.95	4.48	8.22	0.75	4.48
Adipocyte - omental, donor3	11475-119C8	375.11	57.61	10.72	10.72	18.76	12.06	5.02	2.68	1.00	1.67
Adipocyte - perirenal, donor1	11476-119C9	264.13	51.04	9.57	8.93	14.67	7.02	6.38	4.47	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	371.63	49.48	12.09	8.80	14.29	6.60	2.20	2.20	2.20	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	195.10	66.39	5.42	14.90	8.58	7.23	2.26	2.26	2.71	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	234.94	102.88	11.12	10.25	8.34	7.12	9.21	3.48	1.74	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	252.09	43.61	13.10	4.69	4.69	2.54	6.26	4.11	0.78	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	316.58	28.57	5.40	1.29	4.63	2.57	1.54	0.51	0.51	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	392.23	50.18	11.71	5.58	7.25	5.30	6.41	1.95	0.56	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	233.36	74.06	6.47	2.94	2.94	4.70	7.64	1.18	1.18	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	224.17	66.84	15.12	5.79	4.67	3.14	4.02	4.58	1.29	1.21
Adipocyte differentiation, day08, donor2	13023-139D8	211.08	68.42	7.75	3.87	7.75	3.23	5.16	2.58	0.65	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	154.09	57.58	9.06	3.20	5.87	3.20	4.27	4.27	1.60	3.20
Adipocyte differentiation, day08, donor4	13029-139E5	157.47	72.89	6.68	1.11	5.56	2.78	5.01	1.67	0.56	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	282.39	57.39	8.32	2.50	7.07	4.99	7.07	4.57	0.42	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	216.50	61.03	5.02	4.27	5.78	4.77	2.26	2.26	0.75	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	192.75	53.67	5.89	4.91	3.60	6.54	1.96	3.60	1.64	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	173.24	40.19	4.26	3.65	3.35	1.52	1.83	1.22	0.91	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	351.17	48.40	6.63	9.06	3.31	3.31	3.54	3.54	1.99	1.55
Alveolar Epithelial Cells, donor2	11590-120G6	426.00	41.95	8.96	14.34	6.81	5.38	11.12	3.23	1.79	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	336.64	32.35	4.79	29.95	7.19	1.20	1.20	7.19	7.19	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	341.10	106.14	17.99	3.78	4.14	5.40	5.04	1.98	0.90	2.88
Amniotic Epithelial Cells, donor2	11613-122A2	460.21	95.39	10.04	5.02	0.00	8.37	8.37	3.35	0.00	5.02
Amniotic Epithelial Cells, donor3	11694-123A2	549.78	109.71	15.61	7.60	5.75	7.19	10.68	3.90	1.64	3.70
Anulus Pulposus Cell, donor1	11248-116E6	515.95	66.14	13.39	9.61	8.24	5.61	5.95	3.20	1.95	2.98
Anulus Pulposus Cell, donor2	11463-119B5	342.14	45.80	8.33	5.14	9.55	4.16	7.10	1.71	0.49	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	212.52	48.52	4.04	4.94	12.58	4.49	4.49	2.70	0.90	2.25
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	232.27	72.94	5.64	10.42	10.42	3.91	6.08	1.30	1.30	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	184.06	53.51	0.00	14.98	10.70	4.28	8.56	4.28	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	222.40	53.81	7.77	10.16	10.46	3.59	5.38	2.39	0.90	2.99
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	246.61	46.79	10.12	11.38	18.97	7.59	6.32	3.79	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	209.90	57.43	3.30	5.28	6.60	4.62	1.32	0.66	1.32	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	189.73	54.91	5.85	8.12	8.77	4.55	5.52	0.97	2.60	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	258.74	69.42	6.31	7.28	4.85	2.91	3.88	3.40	1.46	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	261.31	59.98	1.19	4.16	8.91	8.31	1.19	1.19	1.19	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	231.63	57.63	3.77	9.79	10.17	3.77	3.77	4.90	0.75	3.39
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	227.86	54.43	5.81	10.16	5.08	2.90	4.35	3.63	1.45	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	218.16	46.39	2.51	7.52	8.78	5.02	3.76	3.76	0.00	6.27
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	299.49	75.61	8.24	10.21	2.47	2.31	3.79	3.46	1.65	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	206.08	75.06	5.46	6.82	5.46	6.82	6.82	2.73	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	188.49	37.55	4.52	5.88	5.88	1.96	2.71	2.11	0.75	1.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	205.21	65.37	5.89	6.97	6.97	4.29	5.36	2.14	1.61	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	265.83	57.25	6.42	6.61	7.94	4.72	5.48	5.10	1.32	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	255.53	61.21	6.68	8.82	10.42	5.88	3.47	4.54	1.34	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	205.82	66.33	5.85	6.83	3.90	4.88	1.95	4.88	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	257.25	53.41	6.63	9.12	5.81	4.15	4.15	1.99	1.66	1.99
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	231.74	78.05	4.80	6.00	12.01	3.60	3.60	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	191.17	46.02	0.00	7.08	14.16	0.00	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	257.64	66.55	5.32	8.40	7.72	4.12	5.49	2.92	1.72	1.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	151.02	71.31	4.19	8.39	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	227.18	60.19	8.74	9.22	13.59	5.34	6.80	0.97	2.43	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	332.02	67.54	6.83	6.45	7.21	4.17	4.17	4.93	1.14	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	274.98	54.51	2.42	7.27	19.38	8.48	3.63	1.21	1.21	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	214.33	51.87	6.27	10.26	7.98	3.99	6.27	4.56	0.57	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	289.24	64.56	5.56	8.98	7.48	4.06	4.28	2.78	2.14	2.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	254.73	58.07	4.13	7.74	8.78	4.39	5.16	2.58	1.81	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	221.93	50.21	7.51	9.38	7.51	3.28	7.51	3.28	0.00	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	307.72	62.70	5.79	6.43	8.04	5.79	5.14	3.86	1.29	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	247.57	58.50	4.99	2.14	8.56	7.13	4.99	2.85	1.43	4.28
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	204.73	51.48	4.68	9.94	9.36	2.92	4.68	1.75	1.75	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	265.55	52.09	4.52	6.02	12.65	5.72	4.82	1.51	0.90	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	324.32	47.52	2.38	7.13	19.01	19.01	9.50	1.19	1.19	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	262.93	53.40	6.10	12.21	9.66	7.63	8.65	4.07	0.51	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	265.89	59.09	7.13	7.90	15.54	9.68	4.84	2.80	0.76	4.58
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	207.77	43.84	1.91	5.08	5.08	5.72	4.45	3.18	1.27	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	230.44	57.83	9.93	6.47	11.65	2.16	1.73	2.16	0.86	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	262.70	53.77	5.93	6.77	7.83	5.08	5.50	3.60	1.91	2.12
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	229.67	50.75	2.61	4.35	7.54	6.67	3.48	2.61	1.16	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	248.47	60.46	5.67	11.34	11.34	6.61	4.72	2.83	0.94	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	267.51	51.37	6.27	9.32	7.46	4.07	5.59	3.05	0.85	2.54
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	282.60	64.86	0.00	9.27	13.90	13.90	2.32	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	177.46	71.83	0.00	14.79	8.45	0.00	2.11	4.23	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	264.58	61.97	3.86	7.72	6.86	4.29	2.79	2.57	1.07	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	222.62	60.77	6.62	4.21	10.83	4.21	3.01	3.01	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	199.01	61.96	6.56	10.93	15.31	5.10	6.56	3.64	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	295.86	68.50	5.75	11.72	8.51	5.98	5.98	4.83	1.15	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	224.43	51.01	2.55	15.30	20.40	2.55	2.55	7.65	0.00	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	171.61	36.36	3.31	5.59	4.58	2.29	2.54	2.29	1.27	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	286.13	71.84	6.40	9.91	7.02	4.54	4.54	5.16	1.03	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	244.80	59.36	3.98	4.59	10.40	2.75	4.59	1.53	1.53	4.59
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	192.64	54.97	6.21	11.47	8.13	2.87	2.87	2.39	1.43	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	253.01	58.32	7.32	5.99	7.98	3.55	4.43	2.44	0.22	2.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	216.66	59.51	3.05	3.05	12.21	6.10	4.58	6.10	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	187.77	48.74	4.98	8.31	6.09	4.43	2.77	2.77	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	229.84	47.13	4.50	7.94	7.15	2.91	4.24	2.65	1.06	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	214.43	50.88	4.00	4.72	6.91	4.00	4.36	3.63	1.09	1.09
Astrocyte - cerebellum, donor1	11500-119F6	1001.57	111.03	31.32	7.61	8.84	8.84	14.86	3.32	1.72	4.30
Astrocyte - cerebellum, donor2	11580-120F5	1086.87	97.22	20.71	7.87	15.92	14.55	26.53	5.82	1.71	4.45
Astrocyte - cerebellum, donor3	11661-122F5	1029.86	68.59	21.81	5.45	13.21	10.07	9.23	1.47	2.10	4.61
Astrocyte - cerebral cortex, donor1	11235-116D2	858.57	45.32	21.61	7.32	12.55	12.20	8.37	2.09	2.79	3.14
Astrocyte - cerebral cortex, donor2	11316-117D2	870.02	55.49	16.82	8.90	20.22	18.93	9.38	3.88	2.59	6.47
Astrocyte - cerebral cortex, donor3	11392-118C6	1173.00	45.94	16.11	8.65	23.57	19.99	6.86	2.98	3.13	6.41
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	104.71	26.49	15.94	19.15	2.64	5.16	12.50	2.18	5.16	1.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	104.23	21.17	13.28	15.53	2.13	4.76	11.28	1.63	4.26	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	92.74	21.51	10.24	13.88	1.14	3.87	7.28	1.59	5.46	0.80
Basophils, donor1	12241-129G9	13.60	25.11	4.45	0.78	0.00	0.00	1.05	1.05	0.00	0.26
Basophils, donor2	12242-129H1	14.79	8.66	2.53	0.00	0.36	0.00	1.80	0.36	0.00	0.00
Basophils, donor3	12243-129H2	102.31	6.76	2.20	0.59	0.29	0.44	1.47	0.73	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	296.24	37.51	7.11	7.11	2.59	3.88	4.96	0.86	2.80	1.51
Bronchial Epithelial Cell, donor2	11591-120G7	1032.78	95.09	14.17	41.60	17.37	7.31	14.17	5.03	3.20	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	337.16	21.52	0.00	0.00	0.00	0.00	7.17	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	324.50	30.75	9.41	12.55	6.90	5.65	10.67	3.14	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	413.82	39.51	9.98	11.85	3.74	6.45	9.57	3.95	1.66	1.66
Bronchial Epithelial Cell, donor6	11461-119B3	318.72	42.14	9.21	16.35	8.98	8.98	6.91	3.22	2.99	2.30
Bronchial Epithelial Cell, donor7	11769-123I5	225.65	25.73	7.74	8.82	6.66	5.76	3.06	1.80	2.34	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	50.60	7.94	1.24	0.72	0.52	0.41	2.47	0.93	0.41	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	59.48	16.63	12.15	0.64	0.64	0.96	2.56	0.32	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	144.79	113.76	0.00	0.00	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.71	0.56	1.13	2.25	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	15.40	4.45	1.11	0.74	0.56	0.74	3.34	0.56	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	7.24	6.37	0.00	0.66	0.44	0.44	1.10	0.22	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	96.52	32.83	2.55	2.26	3.68	1.70	3.40	3.40	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	91.36	27.67	0.38	3.79	2.65	1.90	3.03	1.52	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	107.83	33.53	2.30	3.62	2.30	2.63	3.94	3.29	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	4.19	2.02	0.29	0.00	0.29	0.29	0.58	0.00	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	5.13	5.13	0.00	0.91	0.30	0.60	0.30	0.00	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	6.87	4.97	0.00	0.47	0.24	0.24	0.47	0.24	0.71	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.18	3.18	0.50	0.67	0.00	0.00	0.33	0.17	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.56	4.14	0.00	0.55	0.55	0.28	1.10	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	7.93	3.47	0.00	0.50	0.25	0.25	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.31	3.33	0.39	0.59	0.39	0.20	0.59	0.00	0.20	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.34	4.27	0.36	0.36	0.36	0.18	0.18	0.18	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.40	6.31	0.00	0.65	0.22	0.22	0.65	0.44	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.81	1.64	0.00	0.23	0.00	0.00	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	5.28	0.00	0.53	0.00	0.00	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	2.22	0.00	1.11	0.00	1.11	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.46	1.93	0.45	0.30	0.15	0.15	0.89	0.30	0.00	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.59	3.99	0.40	1.40	0.40	0.20	1.00	0.00	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	5.00	3.12	0.00	0.42	0.21	0.00	0.21	0.42	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3.89	2.75	0.23	0.69	0.46	0.23	0.46	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.43	3.62	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.55	1.75	0.00	0.87	0.87	0.00	0.44	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3.77	3.77	0.27	0.00	0.54	0.00	1.61	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.36	5.41	0.17	1.22	0.35	0.00	1.40	0.87	0.35	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4.63	5.47	0.00	1.26	0.42	0.00	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.14	1.47	0.18	0.55	0.18	0.37	0.55	0.18	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.64	5.64	0.00	0.00	0.70	0.00	0.35	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.58	3.07	0.44	0.88	0.00	0.00	1.32	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.71	1.74	0.52	1.39	0.17	0.17	0.17	0.35	0.00	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.20	6.32	0.00	0.37	0.00	0.74	2.60	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.98	9.48	0.22	1.94	0.65	0.00	0.65	0.43	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	93.36	7.37	2.05	1.23	2.87	0.82	1.23	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.17	3.25	0.00	1.16	0.23	0.46	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.71	2.09	0.00	0.23	0.00	0.00	0.46	0.46	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	8.72	11.33	0.00	0.65	0.87	0.00	0.87	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	6.24	6.24	0.00	1.39	0.23	0.00	0.69	0.46	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	7.80	8.45	0.43	1.73	0.22	0.00	1.08	0.43	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	12.30	7.79	0.47	1.71	0.16	0.16	2.49	0.78	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	11.70	9.08	0.35	0.35	0.17	0.17	1.92	0.35	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	7.36	6.47	0.22	0.67	0.45	0.22	0.67	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	1.79	2.55	0.00	0.77	0.00	0.00	0.26	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	2.42	1.76	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.84	0.84	0.42	0.21	0.00	0.00	0.63	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	2.03	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	2.03	3.39	0.00	0.68	0.00	0.68	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	4.14	4.14	0.00	1.04	0.00	0.00	2.07	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	2.67	1.60	0.53	0.53	0.00	0.00	1.60	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2.68	0.54	0.00	0.00	0.54	0.00	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.81	2.11	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.92	7.06	0.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	7.91	5.27	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	3.63	1.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	4.04	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	237.59	58.99	34.34	0.81	3.23	5.25	5.66	3.64	0.00	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	254.88	57.53	23.17	2.00	4.79	2.80	7.59	2.40	1.60	2.00
CD34+ Progenitors, donor1	11545-120B6	41.17	18.07	4.02	0.00	0.00	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	27.53	20.23	8.99	0.56	1.12	0.00	7.30	1.69	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.59	28.93	3.38	1.13	0.38	0.00	1.88	1.50	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	48.25	27.28	6.09	1.35	0.68	1.35	2.71	0.90	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	5.71	0.36	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	4.90	0.61	1.84	0.00	1.84	0.61	1.84	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	13.11	0.30	0.61	0.00	0.61	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	8.42	1.79	0.26	0.26	0.00	0.26	1.28	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	6.96	2.25	0.22	0.00	0.22	0.00	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	3.16	0.86	0.29	0.00	0.29	0.00	0.86	0.29	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	67.20	11.99	4.19	0.72	1.88	2.02	6.79	0.58	0.14	1.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	113.71	10.00	2.54	0.68	3.39	2.20	7.63	0.34	0.17	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	59.48	8.71	1.77	0.64	2.26	0.48	4.51	0.00	0.32	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	19.28	3.59	0.45	0.00	0.45	0.90	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	23.76	4.19	1.05	0.00	0.00	0.35	3.14	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	16.28	3.52	1.32	0.00	0.44	0.44	0.88	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.09	10.54	0.42	0.42	0.00	0.84	2.95	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	43.22	8.31	0.21	0.83	1.87	0.42	4.78	0.21	0.62	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	25.39	7.02	1.00	1.00	1.67	1.67	3.01	0.33	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.82	0.54	0.00	0.00	0.00	0.00	0.27	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.22	0.00	0.00	0.00	0.00	0.00	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	22.44	4.45	1.11	0.37	0.00	0.37	2.60	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	34.01	8.45	2.17	0.65	2.17	0.87	3.47	0.22	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	39.30	7.36	1.89	0.42	1.47	1.26	4.20	0.21	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.18	2.02	2.53	0.00	0.00	0.00	1.52	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	14.73	2.60	0.43	0.00	0.87	0.00	1.30	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	11.77	0.87	0.87	0.00	0.00	0.44	1.31	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.17	6.43	3.96	0.00	0.99	0.00	2.47	0.49	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	38.77	9.23	1.85	0.00	0.00	0.00	3.69	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	62.81	13.96	4.19	0.00	1.40	1.40	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	30.46	9.69	4.71	0.55	0.83	0.00	1.94	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	40.49	11.78	5.40	0.00	0.98	0.74	2.70	0.25	0.74	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	38.50	9.24	3.08	0.00	0.00	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	49.78	10.03	5.01	0.72	0.72	0.36	3.58	0.72	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	99.72	22.16	11.08	0.00	1.38	0.00	6.92	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	41.58	6.88	4.26	0.00	1.31	0.98	3.27	0.33	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	56.69	10.89	9.01	0.00	1.88	2.25	5.63	0.38	0.75	1.13
CD8+ T Cells, donor3	11383-118B6	24.49	5.05	3.79	0.00	1.26	0.25	2.02	0.00	0.00	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	61.94	26.61	2.52	45.42	8.03	5.73	4.82	1.61	15.60	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	51.76	29.72	1.68	41.46	7.91	5.27	2.88	1.44	16.77	2.40
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	45.14	28.45	1.09	42.13	9.85	4.10	3.83	1.64	15.32	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	44.43	21.31	1.80	60.64	6.60	2.70	3.00	1.80	17.71	2.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	60.24	28.80	1.20	48.72	9.84	7.68	3.60	1.44	20.16	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	57.07	31.83	2.27	50.71	7.05	4.32	4.32	0.91	14.33	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	48.45	29.99	0.87	45.85	6.74	3.48	1.96	2.39	15.21	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	55.01	31.32	0.26	45.80	5.79	2.11	3.16	0.79	16.32	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	58.86	30.02	0.47	47.84	7.50	5.16	4.22	1.64	16.42	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	38.34	27.47	0.60	44.98	7.55	4.23	2.42	1.21	16.30	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	32.25	36.02	1.74	46.77	6.68	5.81	2.32	0.87	12.78	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	37.83	31.71	1.07	53.02	5.06	4.00	2.66	1.87	19.18	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	125.20	27.58	0.44	53.41	2.19	2.19	2.63	1.75	13.13	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	124.79	25.50	1.82	56.47	5.01	2.28	3.19	0.91	18.22	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	160.36	27.60	0.75	46.99	4.48	2.24	0.75	0.00	16.41	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	77.79	20.17	2.52	59.07	3.60	1.80	3.96	1.44	20.53	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	67.04	23.31	1.44	52.65	4.32	3.45	4.89	0.58	15.54	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	55.39	20.98	1.18	60.81	4.01	1.89	4.48	1.65	15.79	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	54.51	38.35	1.90	58.94	2.54	5.39	2.22	2.22	20.60	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	56.59	24.30	1.23	47.36	3.38	2.77	2.77	0.62	22.76	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	51.29	26.93	1.28	45.52	2.24	1.28	3.21	0.64	15.39	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	36.33	22.95	0.76	46.66	5.35	2.68	2.29	1.53	19.51	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	37.83	27.98	0.39	52.81	5.12	1.97	3.94	2.36	13.40	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	36.31	24.96	1.51	45.38	8.32	0.76	2.27	4.54	15.88	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	132.49	14.45	1.61	35.33	2.41	1.61	0.80	0.00	16.86	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	109.81	20.98	0.00	37.77	5.60	2.80	3.50	2.10	20.98	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	111.19	17.03	1.00	42.07	8.01	2.00	2.00	1.00	18.03	2.00
Cardiac Myocyte, donor1	11525-119I4	780.44	193.74	10.97	9.14	25.59	3.66	7.31	1.83	7.31	0.00
Cardiac Myocyte, donor2	11605-120I3	481.74	100.30	7.41	6.42	9.39	3.95	3.95	6.42	2.96	2.47
Cardiac Myocyte, donor3	11686-122I3	469.86	59.46	11.89	11.37	3.16	4.00	4.31	3.79	2.10	2.84
Chondrocyte - de diff, donor1	11261-116G1	381.33	54.08	11.44	11.44	38.83	18.03	8.67	3.12	1.39	0.35
Chondrocyte - de diff, donor2	11338-117F6	390.91	52.95	12.79	6.75	8.53	4.98	5.33	2.84	2.13	1.42
Chondrocyte - de diff, donor3	11410-118E6	371.72	52.34	11.72	7.05	13.43	11.04	6.83	2.73	1.82	1.48
Chondrocyte - re diff, donor2	11339-117F7	407.34	110.12	13.43	36.71	24.17	14.32	7.16	8.95	3.58	1.79
Chondrocyte - re diff, donor3	11411-118E7	260.84	37.21	18.60	11.32	4.85	4.85	4.45	3.24	1.62	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	913.93	114.53	17.33	21.35	14.00	10.67	8.49	6.43	6.31	5.16
Ciliary Epithelial Cells, donor2	11323-117D9	805.04	90.85	10.90	15.82	17.32	16.89	5.56	7.27	3.42	8.76
Ciliary Epithelial Cells, donor3	11399-118D4	977.81	78.94	14.69	18.32	18.58	15.58	6.90	5.75	3.81	6.37
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	317.47	57.04	28.89	11.37	4.31	5.69	7.24	4.22	5.96	2.48
Corneal Epithelial Cells, donor1	11526-119I5	378.98	50.50	10.76	13.17	4.61	4.39	3.73	2.42	3.29	1.10
Corneal Epithelial Cells, donor2	11606-120I4	226.38	28.44	4.55	5.69	1.14	5.69	5.69	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	320.31	39.88	8.69	9.20	4.35	6.14	4.60	0.51	2.56	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	45.73	21.13	0.83	26.42	1.16	1.16	0.33	2.15	8.25	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	53.30	15.46	1.26	25.23	0.63	1.89	0.32	1.26	4.42	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	10.35	0.00	34.51	3.45	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	69.98	16.95	0.76	23.22	2.70	2.27	1.19	1.08	7.99	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	132.90	21.52	8.20	0.34	1.37	2.05	6.15	0.68	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	197.17	24.81	7.18	1.96	0.65	0.65	11.10	0.65	1.31	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	139.38	20.81	10.65	0.00	0.97	2.42	8.71	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	544.50	84.72	14.51	14.01	8.51	7.00	4.84	10.34	2.00	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	596.75	82.15	4.11	9.98	2.93	7.63	4.69	3.52	1.17	2.93
Endothelial Cells - Aortic, donor2	11340-117F8	842.74	133.48	9.33	11.31	9.33	12.73	4.81	6.50	3.11	3.96
Endothelial Cells - Aortic, donor3	11412-118E8	685.71	97.12	5.90	17.69	9.04	7.08	3.93	9.83	3.15	1.97
Endothelial Cells - Artery, donor1	11264-116G4	692.57	68.36	6.40	7.56	15.42	6.69	6.11	4.36	0.58	3.20
Endothelial Cells - Artery, donor2	11341-117F9	600.43	94.11	10.59	14.59	18.35	16.70	8.23	10.59	3.29	5.18
Endothelial Cells - Artery, donor3	11413-118E9	471.58	69.07	9.99	7.89	6.49	8.24	4.21	6.14	2.45	3.33
Endothelial Cells - Lymphatic, donor1	11236-116D3	242.49	68.49	4.65	7.09	3.10	3.55	2.44	4.88	1.77	3.10
Endothelial Cells - Lymphatic, donor2	11317-117D3	255.28	65.72	8.82	4.56	4.26	5.78	1.83	5.17	1.22	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	276.55	55.53	9.58	7.61	2.26	3.66	2.82	5.36	0.28	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	629.33	129.85	10.10	13.07	18.72	10.70	8.62	6.24	1.49	2.97
Endothelial Cells - Microvascular, donor2	11342-117G1	346.76	67.17	6.77	9.37	7.29	7.81	1.56	4.17	1.56	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	647.82	95.42	10.92	14.18	13.61	11.91	8.08	10.63	2.41	4.96
Endothelial Cells - Thoracic, donor1	11266-116G6	456.54	96.03	15.20	9.60	12.00	9.20	6.00	6.40	0.80	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	658.82	91.72	6.29	10.48	18.87	14.68	4.72	7.34	2.62	4.19
Endothelial Cells - Umbilical vein, donor1	11243-116E1	477.73	80.64	14.04	6.34	8.57	8.45	6.09	7.95	1.12	3.60
Endothelial Cells - Umbilical vein, donor2	11324-117E1	552.93	71.91	11.08	6.95	7.82	3.91	7.17	4.78	2.17	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	628.83	68.27	10.38	8.55	5.37	4.89	8.43	8.43	1.95	2.32
Endothelial Cells - Vein, donor1	11267-116G7	747.34	105.79	12.51	17.06	2.28	11.38	9.10	3.41	3.41	0.00
Endothelial Cells - Vein, donor2	11344-117G3	638.43	119.44	6.29	7.68	12.57	13.97	9.08	3.49	4.19	2.79
Endothelial Cells - Vein, donor3	11416-118F3	545.60	88.08	7.69	11.15	11.30	9.11	7.38	9.89	2.98	3.45
Eosinophils, donor1	12244-129H3	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	26.40	3.30	1.65	3.30	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	14.27	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	461.04	45.44	11.48	13.44	2.93	5.38	3.18	1.71	3.42	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	212.18	24.96	8.32	8.32	8.32	4.16	0.00	0.00	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	195.23	0.00	0.00	0.00	0.00	16.27	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	451.57	50.08	10.26	4.93	18.06	11.49	3.69	1.64	1.64	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	126.90	25.29	3.50	3.61	15.11	7.12	3.28	2.63	0.99	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	419.81	55.25	11.59	8.45	54.60	22.21	4.77	3.58	1.19	2.28
Fibroblast - Aortic Adventitial, donor1	11245-116E3	489.00	61.25	15.77	13.83	12.49	10.19	5.46	4.12	3.27	3.15
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	119.28	21.70	3.96	5.73	2.18	1.09	3.00	2.05	1.09	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	506.99	64.76	12.76	11.60	16.24	18.35	6.22	3.80	1.69	3.80
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	226.87	20.82	8.17	6.32	7.38	5.53	2.63	2.63	1.32	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	575.70	76.41	17.94	20.93	17.27	14.95	8.64	5.98	3.99	2.99
Fibroblast - Cardiac, donor1	11268-116G8	661.39	71.67	14.97	12.70	11.34	14.06	7.26	2.72	5.44	3.63
Fibroblast - Cardiac, donor2	11345-117G4	677.61	105.35	7.58	25.01	12.89	8.34	3.03	3.79	2.27	3.03
Fibroblast - Cardiac, donor3	11417-118F4	680.07	78.23	10.72	20.03	15.30	11.67	7.73	6.15	4.42	4.57
Fibroblast - Cardiac, donor4	11452-119A3	479.21	78.50	13.94	11.52	5.76	6.67	3.03	4.55	2.73	3.03
Fibroblast - Cardiac, donor5	11456-119A7	354.06	53.43	5.71	10.91	9.26	5.20	6.09	5.20	2.41	1.78
Fibroblast - Cardiac, donor6	11460-119B2	443.11	63.67	6.67	12.43	11.67	5.76	5.31	3.34	1.82	2.58
Fibroblast - Choroid Plexus, donor1	11492-119E7	858.88	82.14	24.52	5.90	6.43	6.97	4.02	2.68	2.01	2.81
Fibroblast - Choroid Plexus, donor2	11572-120E6	718.33	69.46	10.79	3.45	11.22	15.10	3.45	0.43	0.86	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	908.17	79.10	7.32	16.11	23.44	21.97	13.18	1.46	4.39	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	959.92	86.49	19.83	17.76	3.69	7.61	8.53	4.84	1.61	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	323.27	73.78	13.74	2.20	6.61	5.26	5.26	2.20	0.85	2.04
Fibroblast - Dermal, donor1	11269-116G9	241.36	80.76	5.87	13.85	8.92	4.70	5.63	5.40	3.99	1.17
Fibroblast - Dermal, donor2	11346-117G5	304.23	92.92	4.72	14.62	1.89	5.19	4.25	4.25	3.30	0.94
Fibroblast - Dermal, donor3	11418-118F5	220.62	101.67	7.13	32.40	11.97	8.10	6.29	7.25	6.65	1.45
Fibroblast - Dermal, donor4	11450-119A1	461.79	41.15	9.72	11.30	9.38	8.59	11.87	3.17	1.70	2.26
Fibroblast - Dermal, donor5	11454-119A5	425.32	42.39	8.02	9.77	8.90	8.20	10.99	3.14	0.52	2.27
Fibroblast - Dermal, donor6	11458-119A9	440.17	44.34	5.85	9.26	9.58	9.10	11.53	2.60	2.27	1.95
Fibroblast - Gingival, donor1	11237-116D4	343.58	55.39	8.75	3.96	2.71	3.54	2.71	3.75	1.67	1.87
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	606.01	125.50	11.00	25.68	35.89	30.13	6.29	10.48	2.88	4.45
Fibroblast - Gingival, donor2	11318-117D4	479.83	73.67	11.07	9.09	12.78	11.86	6.06	5.93	2.50	4.22
Fibroblast - Gingival, donor3	11394-118C8	438.38	51.44	12.47	5.22	3.29	6.09	6.86	3.77	0.77	2.42
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	312.71	81.03	11.43	12.47	16.62	9.35	1.04	5.19	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	347.12	76.82	6.17	12.16	15.33	13.22	6.70	4.58	3.17	3.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	564.19	106.32	14.34	21.67	12.94	8.73	5.14	6.24	4.99	3.59
Fibroblast - Gingival, donor6 (control)	11922-125H5	420.15	118.73	10.41	17.31	14.20	14.33	6.22	7.17	2.16	1.89
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1625.72	259.01	28.23	61.40	18.00	17.29	21.53	21.53	13.41	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	508.35	99.59	8.92	15.50	17.40	11.85	4.09	5.41	3.80	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	491.28	114.67	12.41	15.95	17.18	14.73	3.95	5.32	2.86	2.45
Fibroblast - Gingival, donor8 (control)	11926-125H9	446.45	103.88	9.65	31.59	17.11	11.63	6.47	6.14	5.16	1.86
Fibroblast - Gingival, donor9 (control)	11927-125I1	355.84	62.07	14.67	11.89	24.51	16.73	6.90	5.14	2.20	1.47
Fibroblast - Lung, donor1	11270-116H1	720.45	146.81	8.16	21.75	4.08	10.87	5.44	6.80	4.08	1.36
Fibroblast - Lung, donor2	11347-117G6	440.19	80.58	5.97	14.92	16.41	10.45	0.00	2.98	7.46	2.98
Fibroblast - Lung, donor3	11419-118F6	676.37	142.24	12.03	31.23	13.93	13.51	9.29	10.76	6.96	5.49
Fibroblast - Lymphatic, donor1	11506-119G3	1057.10	234.08	48.32	64.98	9.16	12.50	7.50	10.83	6.66	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	675.54	114.69	11.19	11.19	5.59	8.39	8.39	4.20	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	691.57	104.67	9.80	15.95	6.72	2.52	5.88	3.64	1.68	2.24
Fibroblast - Mammary, donor1	11540-120B1	846.85	159.14	23.14	41.81	4.47	8.12	5.28	15.43	8.53	2.84
Fibroblast - Mammary, donor2	11620-122A9	1358.03	139.80	11.98	51.92	19.97	7.99	11.98	3.99	3.99	7.99
Fibroblast - Mammary, donor3	11701-123A9	863.66	59.56	35.74	29.78	0.00	0.00	17.87	5.96	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	468.25	65.56	6.79	8.73	6.21	4.85	2.91	3.30	2.52	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	730.50	64.92	13.80	18.05	8.19	16.99	9.71	5.61	3.19	3.94
Fibroblast - Periodontal Ligament, donor3	11395-118C9	426.24	64.26	9.49	11.63	2.14	4.90	4.28	6.73	1.84	3.37
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	793.01	112.96	11.45	19.08	10.69	8.78	6.87	4.20	2.67	4.20
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	460.87	118.26	7.56	23.22	10.80	8.91	5.40	9.72	3.24	4.05
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	342.70	64.25	5.45	13.68	7.07	6.61	5.10	3.94	2.78	1.39
Fibroblast - Pulmonary Artery, donor1	11250-116E8	439.70	83.56	8.51	14.70	3.98	5.75	4.64	5.64	3.76	1.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	1709.04	222.09	31.70	38.20	8.53	19.30	5.28	13.00	5.69	7.31
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	684.91	85.53	9.35	11.36	3.34	7.35	14.03	4.01	2.67	4.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	508.43	57.33	7.51	5.14	10.28	5.93	4.35	3.16	1.19	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	408.41	32.74	7.54	16.27	14.29	7.54	2.58	4.17	1.39	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	425.04	67.49	13.50	6.93	9.95	7.10	3.37	1.95	2.13	2.31
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	448.96	79.62	12.22	17.15	7.69	9.66	1.97	2.76	3.35	2.96
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	441.66	46.03	7.82	18.35	13.24	6.92	3.31	2.71	2.41	2.71
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	552.28	108.92	18.46	34.65	11.33	11.33	4.97	6.91	3.24	1.94
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	387.20	43.02	10.88	14.17	12.15	6.07	2.53	3.29	1.77	1.77
Fibroblast - skin normal, donor1	11553-120C5	614.80	118.14	14.60	14.11	14.60	13.62	3.61	3.94	3.12	4.43
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	368.53	33.28	9.22	11.83	7.02	5.41	2.41	2.81	2.21	2.81
Fibroblast - skin normal, donor2	11561-120D4	614.13	107.49	25.42	32.45	12.56	11.95	8.14	5.93	3.82	2.61
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	506.55	36.87	16.02	23.88	17.53	7.86	3.63	3.63	1.81	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	477.11	72.08	19.47	14.58	9.86	9.11	4.31	3.65	2.90	2.65
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	453.19	115.39	15.39	15.39	8.72	9.23	5.64	6.50	1.20	2.74
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	509.40	39.41	11.17	12.81	13.47	7.23	4.60	0.99	1.64	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	736.60	103.65	18.43	26.63	13.00	13.00	6.82	6.60	2.98	3.73
Fibroblast - skin walker warburg, donor1	11554-120C6	902.44	103.23	14.68	16.70	12.65	12.65	5.23	3.20	1.86	5.06
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	453.52	85.47	24.93	23.68	59.28	17.25	3.29	5.80	3.14	8.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1861.42	332.40	66.48	132.96	110.80	22.16	44.32	22.16	66.48	88.64
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	308.52	45.32	7.84	7.84	7.84	5.23	10.46	0.87	1.74	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	201.79	52.01	9.53	7.80	4.68	3.47	1.91	2.60	1.56	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	249.83	45.80	8.33	4.16	5.99	5.20	2.60	3.38	2.08	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	245.55	46.25	12.26	4.60	4.34	2.56	3.83	2.30	0.00	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	904.12	67.37	16.84	14.55	39.04	22.20	16.84	1.53	4.59	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	729.32	49.13	16.59	13.40	33.82	23.61	11.49	0.64	3.83	5.10
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	515.47	25.67	15.12	5.42	48.49	19.68	12.55	2.57	1.43	3.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3886.25	72.52	37.78	56.81	256.18	111.41	27.30	16.55	11.03	6.62
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1607.42	52.06	15.07	26.49	68.27	37.45	18.49	5.48	6.39	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1054.25	36.85	18.82	14.66	59.84	30.91	21.40	4.36	4.56	4.16
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3950.75	66.61	31.46	52.87	262.75	118.16	30.66	16.92	13.48	10.57
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	1636.28	55.12	15.00	20.87	44.68	29.03	17.94	3.59	5.87	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	409.50	23.00	11.06	5.75	31.40	12.38	12.82	3.10	2.21	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	656.30	73.20	15.97	7.49	13.00	10.03	16.11	2.69	3.25	3.53
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	738.61	58.99	13.18	7.88	16.38	15.39	13.67	3.32	2.71	3.69
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	457.74	66.35	10.21	6.98	10.21	7.79	11.28	5.10	2.15	2.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	941.10	52.28	9.79	26.39	26.39	19.58	11.52	4.46	5.82	5.95
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	811.04	52.74	10.38	19.38	19.52	13.01	11.90	5.26	6.23	5.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	517.00	51.03	12.20	14.84	16.47	11.59	5.69	2.85	5.69	4.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	839.93	82.37	13.01	16.20	30.12	17.80	9.81	4.11	3.42	6.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	818.65	75.24	12.95	13.70	16.07	15.32	7.85	3.24	4.24	4.36
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	757.80	86.12	11.58	14.21	15.30	12.68	7.87	4.15	4.37	3.72
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	870.19	104.01	8.57	13.00	26.89	17.14	10.93	4.73	2.36	7.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	921.96	67.24	14.47	8.27	19.71	15.90	11.13	4.93	3.81	4.29
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	902.62	96.74	14.97	15.86	17.20	11.62	8.49	4.92	2.90	6.03
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	913.80	81.46	12.70	13.11	23.59	16.33	10.28	6.45	2.22	3.83
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	972.22	81.26	11.03	13.06	21.37	13.74	8.99	4.07	4.07	4.58
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	875.81	125.29	20.04	16.85	24.38	20.39	7.71	7.54	4.61	6.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1195.50	181.27	23.10	17.48	29.76	28.93	12.90	11.13	5.93	6.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1304.73	189.39	13.49	16.05	29.20	21.52	11.78	6.32	5.12	4.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	888.77	80.89	12.06	10.84	19.25	13.28	12.17	4.32	2.10	3.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	790.45	108.99	18.30	12.40	18.55	15.72	7.90	6.24	3.74	4.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	900.23	115.97	8.78	8.37	16.95	13.07	7.15	4.49	3.06	4.90
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	880.72	104.60	13.20	9.70	25.38	17.95	9.90	4.95	3.51	5.98
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	954.40	90.39	15.33	8.88	20.98	12.57	10.38	3.80	2.77	4.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	687.40	82.72	10.51	10.84	13.17	10.34	7.17	5.17	2.67	3.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	831.02	113.30	10.58	9.70	21.38	14.77	8.60	5.07	2.87	3.75
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	815.93	107.00	13.04	8.24	19.43	14.39	9.96	5.53	3.44	5.41
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	900.10	84.94	10.05	13.62	22.86	13.29	11.99	5.35	3.08	4.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	718.40	123.80	7.06	9.62	19.88	18.28	11.55	5.13	4.17	5.77
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	802.66	93.24	12.32	11.56	18.48	12.41	9.48	5.78	3.41	3.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	606.61	78.61	6.80	9.49	12.34	8.54	9.33	4.27	3.32	4.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	831.98	117.68	6.99	11.25	34.06	22.81	9.12	6.99	3.34	4.56
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	747.66	80.29	9.62	13.07	15.79	15.79	8.26	6.27	2.40	4.50
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	490.05	77.28	7.03	5.71	12.51	9.22	6.59	3.07	1.98	3.51
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	770.11	94.26	9.26	11.22	22.16	17.67	8.42	5.05	3.09	4.49
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	688.85	77.31	5.46	8.70	13.80	13.15	6.57	3.61	2.96	7.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	566.36	85.57	6.42	8.56	14.97	10.16	7.49	2.94	2.14	2.67
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	583.41	96.24	6.12	13.01	16.37	8.42	4.90	7.34	2.91	4.28
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	697.43	83.29	4.02	12.44	13.99	10.88	6.87	4.53	2.33	2.85
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	492.54	76.44	4.61	6.78	9.22	6.51	8.40	2.71	2.17	2.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	705.14	71.71	10.32	7.01	15.12	12.72	5.35	3.32	2.58	4.79
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	805.54	84.00	8.33	10.09	18.20	12.94	7.24	4.39	2.41	6.80
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	1049.27	89.26	14.88	8.93	10.91	10.91	11.90	3.97	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	812.97	78.88	10.16	10.16	19.13	13.59	5.41	5.01	1.85	5.28
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	709.38	76.06	6.66	7.67	16.95	11.30	4.44	3.23	2.22	4.04
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	923.87	141.31	41.68	31.01	11.44	20.08	10.67	6.35	4.32	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	523.53	52.35	22.49	10.75	12.34	10.55	19.31	2.19	1.39	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	584.41	55.31	17.10	6.63	10.48	8.01	15.72	3.54	2.16	3.70
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	912.44	55.24	19.84	6.55	11.46	12.27	19.64	3.48	4.09	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	744.15	40.37	11.89	4.07	13.46	12.83	11.58	1.88	1.88	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	709.50	38.71	9.04	5.37	13.56	8.19	10.74	1.98	2.83	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	613.86	27.21	5.07	3.69	29.52	16.14	10.61	0.92	0.46	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1061.69	69.29	2.47	9.90	34.65	34.65	9.90	4.95	4.95	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	976.31	65.76	15.09	8.51	34.81	24.37	10.06	1.55	1.93	3.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1196.93	57.76	9.63	3.21	40.11	28.88	17.65	3.21	6.42	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1177.19	60.86	10.43	8.69	43.47	27.82	8.69	0.00	3.48	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1065.29	62.17	9.11	7.16	34.18	25.06	7.16	2.60	2.28	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	907.20	54.36	10.30	7.00	32.12	24.71	6.18	2.06	2.06	4.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1432.88	86.64	3.33	6.66	73.31	53.32	10.00	0.00	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	970.94	49.78	7.83	6.99	38.03	20.13	10.91	3.36	1.68	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1154.08	62.75	12.42	7.52	33.34	20.92	7.84	4.25	3.27	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1337.94	47.81	12.58	8.39	58.72	36.91	6.71	1.68	1.68	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1302.50	60.12	11.13	13.04	41.03	30.22	7.95	2.54	3.18	4.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1140.25	60.12	7.47	5.09	31.25	21.06	7.81	3.74	3.06	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	1050.34	52.20	8.35	8.35	29.23	31.32	4.18	2.09	0.00	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1496.46	60.71	19.47	6.87	48.11	30.93	14.32	4.01	4.01	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1301.14	54.16	13.91	7.40	43.81	29.89	12.14	4.14	3.26	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1013.10	52.52	11.86	3.39	59.30	33.88	6.78	0.00	1.69	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1190.43	65.03	18.23	7.87	37.28	28.58	8.70	2.49	2.49	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1330.15	77.32	21.17	7.82	53.39	29.69	9.44	5.29	4.14	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	1317.12	47.42	21.07	0.00	52.68	42.15	5.27	0.00	5.27	15.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1027.92	45.36	13.45	5.77	30.75	29.60	8.07	3.46	2.69	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	969.11	41.72	8.48	4.56	35.20	24.12	4.24	2.61	2.61	5.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1377.14	39.46	9.36	8.03	42.14	32.10	12.71	1.34	4.01	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1164.66	40.84	11.56	5.01	51.24	30.05	13.48	5.39	3.08	7.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1238.24	57.17	17.46	11.64	42.11	26.36	10.27	3.42	2.05	4.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	1510.75	54.67	7.45	17.39	94.42	59.63	9.94	7.45	2.48	14.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1440.09	46.71	13.68	8.02	52.38	32.56	9.44	3.30	2.83	5.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1382.60	49.49	12.07	9.05	43.45	26.55	15.69	2.41	1.21	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1290.51	44.25	10.17	8.14	47.82	28.49	14.75	2.03	4.07	6.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1151.45	59.83	16.35	9.57	68.60	45.87	10.37	1.99	3.59	3.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	958.59	41.94	12.33	4.44	29.11	16.77	8.39	2.96	2.96	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	841.65	43.68	5.90	11.80	37.77	18.89	10.62	3.54	2.36	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	1147.06	43.18	11.67	5.83	46.09	26.26	6.42	3.50	0.58	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	983.97	33.79	13.17	6.14	29.84	19.75	6.58	2.19	2.19	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	767.16	37.30	8.48	5.93	25.43	13.56	6.78	0.00	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	727.64	35.81	11.94	5.37	25.07	18.50	10.74	0.60	2.39	4.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	723.02	42.70	12.62	5.82	27.66	14.07	4.85	3.88	0.97	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	567.23	123.26	14.84	10.27	10.27	9.13	5.71	4.57	1.14	5.71
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	731.42	128.07	12.06	5.82	13.31	15.80	6.65	7.48	1.25	6.24
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	915.31	197.90	14.62	14.62	24.74	19.12	3.37	4.50	3.37	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	326.36	59.31	8.88	6.66	6.98	5.71	6.66	1.27	1.59	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	342.13	55.56	7.52	5.43	3.34	3.76	6.27	2.09	0.84	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	567.56	71.48	21.00	9.98	14.97	11.26	9.05	3.71	3.02	2.90
Hep-2 cells mock treated, biol_rep2	11899-125E9	717.74	77.31	13.17	7.43	15.02	12.32	5.57	3.04	2.19	3.88
Hep-2 cells mock treated, biol_rep3	11900-125F1	601.06	78.26	15.47	10.92	14.56	9.10	5.01	2.96	2.96	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	572.12	74.55	18.80	11.59	19.57	12.02	7.00	3.94	3.17	6.45
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	697.39	81.88	15.26	9.24	13.54	10.75	7.52	2.58	3.01	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	571.36	73.63	11.63	9.26	11.63	7.32	7.10	3.88	2.80	6.24
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	568.51	69.37	17.19	8.97	14.07	10.21	6.85	4.86	2.12	4.61
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	676.76	65.36	12.87	4.46	11.49	8.58	8.06	2.92	1.89	4.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	560.97	74.65	15.38	10.25	12.49	10.25	4.16	1.92	1.92	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	578.09	100.17	17.91	14.55	12.31	11.75	17.35	11.19	1.12	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	841.78	125.08	9.09	20.77	12.12	11.25	7.36	10.39	3.03	3.90
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	327.83	55.52	2.64	5.29	18.51	13.22	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	972.10	126.27	16.23	13.05	5.64	9.52	5.64	4.94	3.17	6.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	1007.67	95.17	5.09	10.90	14.53	15.26	7.99	0.73	0.73	4.36
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	429.58	63.12	6.47	9.27	10.32	7.69	5.25	2.10	2.10	3.32
Hepatocyte, donor1	11523-119I2	1578.63	96.85	20.58	6.05	44.79	33.90	1.21	3.63	0.00	3.63
Hepatocyte, donor2	11603-120I1	1079.49	57.10	11.85	7.54	38.78	29.09	3.23	3.23	1.08	4.31
Hepatocyte, donor3	11684-122I1	739.31	86.51	14.11	9.82	26.38	14.11	4.29	5.52	1.23	4.29
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	40.47	4.57	2.61	0.00	1.31	0.00	7.83	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	651.41	55.06	21.32	5.42	12.41	11.54	3.32	1.75	1.05	2.10
Iris Pigment Epithelial Cells, donor1	11530-119I9	352.07	52.96	6.59	8.64	6.59	4.53	3.16	3.57	1.78	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	347.04	79.60	3.18	19.10	9.55	6.37	6.37	6.37	6.37	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	246.99	53.40	6.68	13.35	13.35	6.68	6.68	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	406.25	108.33	0.00	0.00	27.08	0.00	27.08	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	264.42	92.75	6.92	9.69	6.92	4.15	9.69	4.15	5.54	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	262.78	132.64	2.50	12.51	7.51	10.01	7.51	0.00	5.01	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	296.71	59.34	23.74	11.87	11.87	11.87	0.00	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	263.98	64.07	5.13	15.38	5.13	2.56	5.13	10.25	7.69	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	306.24	109.70	0.00	22.85	4.57	0.00	4.57	0.00	9.14	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	302.13	107.21	11.37	17.87	3.25	3.25	9.75	1.62	4.87	8.12
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	243.43	105.04	3.33	15.01	5.00	1.67	3.33	5.00	3.33	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	268.66	65.35	0.00	7.26	3.63	7.26	7.26	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	295.13	105.88	5.29	21.18	5.29	2.65	11.91	5.29	5.29	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	263.86	84.26	7.76	15.52	6.65	4.43	8.87	2.22	3.33	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	225.25	157.15	5.24	5.24	5.24	5.24	5.24	15.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	195.89	78.10	6.30	9.45	4.41	3.78	8.19	8.82	1.89	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	236.63	109.81	10.83	20.11	6.19	4.64	7.73	4.64	9.28	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	175.62	58.54	0.00	0.00	14.63	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	263.58	76.23	10.98	12.27	5.17	1.94	5.81	5.81	3.23	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	289.79	109.47	4.83	16.10	3.22	6.44	19.32	4.83	3.22	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	358.45	107.53	0.00	11.95	11.95	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	245.28	79.86	7.33	15.48	4.07	6.52	7.33	6.52	0.00	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	274.98	159.11	8.40	26.87	0.84	2.94	10.50	8.82	3.36	2.94
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	86.23	0.00	43.12	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	200.92	90.01	8.84	24.11	5.63	4.82	8.84	6.43	2.41	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	228.97	86.79	3.69	13.85	1.85	4.62	10.16	4.62	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	286.53	30.16	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	219.97	81.19	5.66	12.75	4.25	7.08	8.97	2.36	2.83	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	206.79	77.09	7.26	14.51	4.53	4.53	4.53	4.53	3.63	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	44.23	0.00	0.00	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	258.27	90.39	13.99	10.76	2.15	3.23	12.91	5.38	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	312.53	94.01	7.62	19.06	6.35	3.81	2.54	7.62	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	295.75	65.72	16.43	0.00	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	260.17	109.04	10.84	19.77	0.64	3.19	8.93	12.12	2.55	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	293.45	98.42	3.65	14.58	5.47	7.29	12.76	3.65	7.29	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	252.87	79.02	0.00	31.61	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	247.07	91.40	10.71	14.28	4.28	3.57	8.57	2.86	2.14	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	265.47	92.91	0.00	3.32	3.32	6.64	3.32	3.32	6.64	13.27
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	333.58	83.39	0.00	20.85	41.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	193.22	73.77	5.56	16.36	3.40	2.78	8.03	5.86	2.78	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	279.21	101.85	7.02	8.78	0.00	3.51	10.54	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	308.03	103.72	6.29	6.29	6.29	6.29	9.43	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	215.57	75.10	6.26	8.34	4.87	3.48	6.95	4.17	3.48	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	329.75	126.15	11.07	26.56	6.64	11.07	8.85	6.64	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	317.72	106.99	9.73	6.48	0.00	0.00	12.97	3.24	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	271.17	90.68	14.82	16.57	2.62	3.49	13.95	3.49	7.85	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	303.72	112.49	13.50	11.25	6.75	0.00	20.25	9.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	292.70	108.02	17.42	24.39	3.48	10.45	6.97	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	237.89	109.88	14.93	11.73	3.20	4.27	20.27	8.53	3.20	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	282.63	105.29	15.24	18.01	2.77	2.77	11.08	2.77	2.77	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	259.31	76.94	2.85	8.55	5.70	5.70	5.70	0.00	0.00	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	325.83	79.16	9.20	12.89	5.52	7.36	12.89	4.60	4.60	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	181.52	108.91	9.08	21.18	3.03	0.00	15.13	9.08	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	279.39	99.34	6.21	43.46	0.00	0.00	0.00	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	260.11	132.17	16.92	22.20	9.52	4.23	22.20	6.34	2.11	4.23
Keratinocyte - epidermal, donor1	11272-116H3	265.52	39.98	12.81	4.90	9.63	6.28	3.10	2.20	1.06	1.14
Keratinocyte - epidermal, donor2	11349-117G8	272.91	43.34	10.54	4.10	2.93	3.51	1.76	1.76	1.76	0.00
Keratinocyte - epidermal, donor3	11421-118F8	277.06	19.78	8.99	1.99	4.83	5.02	6.91	0.38	1.80	1.23
Keratinocyte - oral, donor1	11251-116E9	325.23	34.74	17.25	10.33	3.52	3.97	3.97	1.93	4.09	1.70
Keratocytes, donor1	11527-119I6	520.56	80.46	9.28	15.47	5.50	5.16	9.63	4.81	3.78	2.75
Keratocytes, donor2	11607-120I5	606.99	64.45	15.23	18.75	7.03	8.20	12.89	3.52	2.34	4.69
Keratocytes, donor3	11688-122I5	160.25	55.33	7.11	6.13	6.32	4.54	6.72	1.58	0.59	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	1044.01	30.77	6.59	4.40	4.40	4.40	10.99	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	633.22	39.91	8.63	5.39	5.39	2.16	3.24	1.08	1.08	3.24
Lens Epithelial Cells, donor2	11609-120I7	820.13	55.71	11.76	9.23	8.07	8.30	7.15	4.04	1.73	2.65
Lens Epithelial Cells, donor3	11690-122I7	549.96	71.34	7.16	11.20	4.24	4.64	3.83	4.04	4.64	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	289.33	57.15	6.05	5.93	7.11	7.11	4.98	5.10	0.71	1.78
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	197.86	56.09	6.14	6.42	4.47	6.42	3.63	4.19	0.56	3.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	191.41	48.48	5.19	4.56	5.67	5.51	4.25	3.15	1.57	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	218.31	58.07	3.76	8.07	3.23	4.84	3.23	2.69	1.08	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	216.20	75.01	3.78	6.62	17.65	12.61	5.36	4.10	0.00	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	211.75	52.07	5.28	5.39	4.96	5.61	5.39	3.34	0.97	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	210.94	49.66	3.69	4.51	3.28	5.34	3.28	0.82	0.41	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	273.05	79.13	7.58	8.60	6.07	6.07	6.32	3.29	1.52	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	194.66	56.58	5.91	6.33	6.19	4.36	3.80	5.21	0.84	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	194.21	57.75	6.72	7.12	3.56	5.93	1.58	4.75	0.79	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	215.41	65.34	6.01	7.95	5.82	5.23	4.27	5.04	1.36	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	201.26	62.95	5.74	5.37	3.70	2.22	6.48	4.07	1.30	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	230.66	59.58	3.14	4.53	4.18	7.32	3.48	1.74	1.05	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	236.14	67.26	7.16	5.96	4.53	5.01	4.29	3.82	0.24	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	187.21	51.51	7.00	6.18	4.26	4.67	6.46	3.30	1.10	1.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	233.43	48.35	3.08	7.08	7.08	4.31	4.31	4.00	0.92	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	232.25	72.95	5.61	5.30	5.92	5.30	3.74	4.05	0.94	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	223.43	59.65	8.42	6.04	6.04	6.95	6.22	5.31	1.28	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	244.20	56.94	3.62	5.27	6.58	5.59	5.27	2.63	0.99	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	236.05	62.97	6.15	6.44	6.74	5.27	3.22	3.22	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	206.61	61.49	5.97	8.21	6.22	5.73	4.23	3.98	1.24	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	246.85	53.83	2.91	5.33	4.36	2.91	2.42	2.42	1.94	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	211.13	59.51	6.46	6.19	5.66	4.31	3.77	4.31	0.54	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	183.92	52.98	5.00	7.72	6.36	6.21	4.69	3.63	1.21	1.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	201.14	53.40	6.22	4.15	3.11	4.67	4.67	0.00	2.07	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	224.89	63.86	5.03	6.91	10.47	6.07	3.98	4.82	0.42	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	205.11	50.52	5.11	8.57	3.16	7.67	4.21	4.06	1.05	1.35
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	277.90	63.28	3.44	9.63	7.57	6.19	3.44	4.13	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	225.59	59.83	7.90	8.28	6.21	4.33	2.26	4.70	1.32	1.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	219.59	52.27	5.30	7.74	5.30	6.26	5.73	5.83	1.59	2.01
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	275.24	58.15	5.33	7.27	5.81	6.30	2.42	3.39	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	217.66	69.47	4.63	7.94	9.92	3.97	2.98	2.98	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	223.01	53.65	6.57	8.42	5.20	4.71	5.20	5.20	0.99	2.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	270.99	53.68	4.07	8.14	6.29	6.29	4.44	5.18	0.37	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	207.06	63.25	4.20	5.93	4.45	3.95	4.45	4.20	1.24	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	213.25	54.58	4.67	11.96	5.91	6.74	5.36	4.12	0.82	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	249.91	53.71	3.54	9.01	3.54	4.18	2.89	4.18	0.64	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	201.16	61.78	5.17	7.00	7.00	6.09	1.83	3.96	1.22	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	208.97	54.59	5.60	7.42	5.32	2.80	5.46	4.76	1.26	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	235.74	55.47	4.27	7.11	3.91	3.91	2.13	2.49	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	224.45	83.38	2.91	9.70	8.24	9.21	2.42	4.36	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	226.41	61.93	7.47	9.80	5.60	6.69	4.51	5.91	1.40	2.02
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	262.49	61.59	3.22	8.59	5.01	5.01	5.37	3.94	1.79	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	223.45	65.66	8.17	11.43	2.94	3.92	2.29	5.23	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	215.65	65.92	2.83	7.53	5.41	6.36	5.89	4.24	1.18	1.88
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	295.64	65.46	8.79	10.15	5.32	6.31	4.21	3.47	1.61	1.73
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	271.24	69.67	6.15	12.29	7.68	7.43	6.40	6.15	1.54	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	247.34	53.41	5.07	6.86	5.07	6.56	3.58	2.98	0.60	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	444.14	33.99	36.26	4.53	0.00	2.27	0.00	2.27	4.53	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	573.82	40.66	23.78	14.58	10.74	11.51	7.67	1.53	3.07	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	500.26	37.85	15.59	7.42	7.42	8.16	1.48	0.00	4.45	5.20
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	484.91	45.27	19.04	12.69	15.23	14.81	2.54	3.39	3.81	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	549.30	33.06	21.10	16.18	19.69	12.66	6.33	1.41	3.52	7.03
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	547.30	37.36	19.61	10.27	9.34	5.60	3.74	0.93	0.93	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	438.49	39.68	16.49	14.43	23.19	25.76	1.03	1.03	2.58	6.18
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	491.25	30.93	22.60	8.33	10.71	5.95	5.95	1.19	3.57	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	501.70	45.46	30.31	13.80	6.11	5.65	3.62	1.13	4.30	4.30
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	368.77	32.86	15.41	8.43	16.00	14.54	2.33	0.87	3.49	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	471.33	31.96	25.21	9.00	19.36	14.41	1.80	0.90	1.80	4.50
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	581.91	51.48	35.23	18.70	7.32	9.21	5.28	2.57	4.88	5.69
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	473.98	38.51	15.92	11.81	22.60	18.49	2.05	1.03	3.59	5.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	498.94	33.52	18.70	8.12	11.64	5.65	5.29	2.47	2.12	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	439.10	35.98	13.99	9.99	14.66	11.33	4.66	1.33	4.00	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	460.99	40.24	20.88	13.24	15.28	9.17	1.53	2.04	4.58	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	489.86	32.55	22.68	9.34	14.14	12.01	1.60	1.07	2.40	5.34
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	430.23	37.22	14.17	10.58	8.31	9.45	2.83	1.32	3.97	4.16
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	466.92	31.91	12.27	14.73	16.57	10.43	3.68	3.07	4.29	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	598.52	38.32	29.36	17.12	13.86	13.86	4.08	0.82	4.08	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	464.38	32.69	18.95	9.37	13.95	13.33	2.92	1.46	2.50	4.79
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	429.64	35.03	13.17	10.09	30.55	14.01	1.68	1.96	4.76	3.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	630.57	30.91	11.33	10.30	13.39	17.52	4.12	0.00	4.12	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	506.00	33.09	19.16	10.16	16.55	14.52	4.94	2.03	0.87	4.94
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	438.83	30.19	9.86	11.96	11.66	7.47	2.39	0.30	3.29	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	468.61	37.07	16.60	11.07	11.07	12.72	8.85	1.11	3.87	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	608.00	35.00	23.33	15.20	16.26	14.85	6.72	2.47	4.24	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	455.44	41.30	20.28	12.17	14.38	12.54	2.21	1.48	4.06	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	488.14	42.60	23.03	9.21	23.03	11.51	1.15	0.00	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	562.97	39.53	17.65	12.66	14.58	12.28	3.07	2.30	5.37	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	413.28	35.10	19.81	17.55	18.12	16.98	1.13	0.57	3.96	5.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	472.59	45.13	23.79	13.95	6.56	10.67	3.28	1.64	5.74	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	530.96	34.34	19.43	7.23	8.13	14.46	4.97	3.62	6.33	4.52
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	474.69	33.75	17.95	16.52	10.77	9.34	4.31	0.72	6.46	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	642.34	47.05	26.14	14.94	8.22	13.44	2.99	2.24	5.23	7.47
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	503.51	44.59	23.41	15.61	11.89	17.09	4.83	1.86	5.95	5.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	461.33	36.61	18.95	7.75	16.37	9.48	1.72	1.72	2.58	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	547.17	33.40	17.98	12.84	11.13	18.84	4.28	0.86	6.85	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	567.73	44.65	22.66	16.66	16.33	12.99	4.00	2.33	8.00	3.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	514.02	39.82	14.48	14.48	15.69	12.07	3.02	2.41	4.22	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	566.67	36.97	22.04	15.64	4.27	9.95	5.69	3.55	3.55	4.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	521.08	41.25	24.06	13.75	13.75	14.09	3.78	1.03	3.09	4.47
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	486.83	53.14	20.40	13.96	16.64	14.49	4.83	1.07	4.83	4.83
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	561.58	43.10	22.22	11.45	12.12	12.79	3.37	1.35	1.35	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	630.80	43.34	21.11	12.96	17.78	16.67	6.30	1.85	4.44	4.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	424.47	51.17	29.07	19.77	4.65	4.65	5.81	2.33	3.49	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	552.14	30.67	24.33	26.44	10.58	7.40	3.17	1.06	3.17	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	653.45	37.21	26.41	22.01	15.61	13.20	8.80	2.00	4.80	6.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	450.66	29.80	19.63	10.90	7.27	8.00	3.63	0.73	1.45	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	598.65	33.73	29.89	16.86	9.20	6.13	5.37	1.53	3.07	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	477.49	31.57	23.68	11.84	13.32	15.29	3.45	0.99	5.92	3.95
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	446.94	47.99	17.88	13.17	18.82	8.47	4.70	2.82	0.94	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	544.05	38.21	20.62	13.58	12.07	7.54	6.03	1.01	3.02	4.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	598.88	36.95	19.38	11.27	10.81	15.77	6.76	2.25	2.25	4.06
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	404.46	36.14	17.21	12.05	18.93	15.49	5.16	0.00	3.44	6.88
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	521.94	35.18	22.71	16.03	15.59	16.92	5.34	3.56	1.78	5.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	509.12	35.58	18.38	10.95	9.38	14.47	7.04	0.78	3.13	6.65
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	420.91	29.69	18.47	11.22	12.53	10.56	1.32	1.32	3.30	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	525.15	39.44	22.31	15.05	5.19	9.34	3.11	0.52	2.59	4.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	491.39	35.88	25.38	10.94	10.06	14.00	3.94	3.06	3.94	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	443.93	38.02	13.42	8.95	16.21	7.27	1.12	1.68	1.12	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	499.50	39.31	18.99	10.16	8.39	11.04	4.42	1.32	0.88	3.53
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	546.94	38.57	16.59	10.80	18.13	13.11	4.63	1.54	4.24	5.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	428.88	44.05	16.20	11.14	20.25	11.65	4.56	1.01	3.04	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	597.89	34.12	18.26	16.82	6.73	8.17	5.29	0.96	3.84	5.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	561.34	39.75	18.29	15.50	13.12	13.91	5.17	2.39	4.77	5.96
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	542.00	32.81	14.58	18.84	17.01	10.33	3.65	2.43	3.04	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	379.05	35.28	17.98	14.53	18.68	12.45	5.53	2.08	0.69	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	525.53	34.58	19.76	14.82	11.40	11.78	4.56	1.90	3.04	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	467.36	39.25	14.46	9.81	20.14	17.04	1.03	0.00	4.13	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	461.96	44.74	15.72	26.60	9.67	10.88	6.65	2.42	1.81	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	594.51	36.44	19.33	13.63	13.31	10.77	6.02	1.90	3.49	5.39
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	509.63	38.38	15.99	13.33	8.00	5.33	4.80	0.53	3.20	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	383.88	43.67	22.41	22.99	8.62	8.05	4.02	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	595.48	41.14	20.06	16.46	19.54	14.91	5.14	2.06	3.60	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	495.15	43.86	16.98	14.85	16.98	16.27	4.24	0.00	4.24	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	406.32	38.02	22.70	19.86	11.92	6.81	1.70	3.40	1.70	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	636.52	37.03	22.47	17.47	14.14	15.81	7.49	1.25	4.58	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	514.46	35.24	26.62	14.88	17.23	10.18	3.13	0.00	4.70	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	427.99	34.24	20.46	19.62	7.10	11.69	6.68	0.84	2.09	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	586.37	40.42	20.91	15.33	11.62	10.69	4.65	0.46	4.18	4.65
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	484.39	34.12	20.07	18.73	20.74	9.37	3.35	2.68	5.35	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	510.58	37.42	33.15	20.32	7.48	7.48	6.95	3.21	3.74	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	511.99	44.85	29.90	16.16	16.16	9.29	5.66	0.81	6.47	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	581.86	46.81	16.52	11.01	20.19	6.42	5.51	0.92	1.84	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	592.15	57.79	30.23	18.67	26.67	13.34	2.67	0.89	0.89	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	585.26	27.35	19.38	11.97	12.54	11.97	4.56	1.14	0.00	5.70
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	621.19	32.98	16.10	16.10	19.94	13.04	4.60	0.77	8.44	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	515.44	42.13	34.47	29.00	21.34	13.13	6.57	2.19	5.47	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	638.77	46.77	23.16	14.70	8.91	12.92	4.90	3.12	5.35	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	547.21	46.53	28.08	19.50	5.20	6.24	4.94	2.86	7.80	4.42
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	562.98	45.75	29.18	23.87	20.56	15.91	3.98	3.32	5.97	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	688.02	64.44	27.02	22.86	24.94	31.18	0.00	0.00	2.08	8.31
Macrophage - monocyte derived, donor1	11232-116C8	92.31	31.91	1.60	2.96	1.14	0.68	5.01	2.51	1.14	0.23
Macrophage - monocyte derived, donor2	11313-117C8	55.24	15.05	1.65	12.85	0.73	1.47	1.47	1.28	6.06	0.55
Macrophage - monocyte derived, donor3	11389-118C3	126.36	20.84	1.97	11.01	3.01	2.23	5.11	1.84	3.93	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	280.38	54.70	6.90	2.66	2.66	0.53	4.25	1.59	1.06	1.59
Mallassez-derived cells, donor2	11929-125I3	447.15	49.91	9.82	3.80	5.07	3.96	3.49	2.69	1.58	3.33
Mallassez-derived cells, donor3	11930-125I4	305.63	46.42	9.45	5.00	3.34	2.92	2.36	2.36	2.36	2.08
Mammary Epithelial Cell, donor1	11273-116H4	306.70	71.94	15.44	14.15	4.58	6.28	4.68	3.89	3.69	1.59
Mammary Epithelial Cell, donor2	11350-117G9	330.09	81.65	10.71	11.87	9.27	5.21	4.05	4.05	1.45	2.03
Mammary Epithelial Cell, donor3	11422-118F9	411.06	74.08	17.46	10.48	3.74	4.74	3.24	3.24	1.25	1.50
Mast cell - stimulated, donor1	11487-119E2	13.56	33.22	8.14	10.17	0.00	0.68	1.36	1.36	1.36	0.68
Mast cell, donor1	11563-120D6	95.06	54.94	8.00	18.28	5.41	3.89	3.24	5.30	3.57	0.87
Mast cell, donor2	11565-120D8	110.25	69.84	9.21	19.02	6.54	8.62	10.10	5.94	3.57	0.59
Mast cell, donor3	11566-120D9	106.26	52.90	9.46	9.00	4.73	5.85	12.38	2.70	1.80	1.13
Mast cell, donor4	11567-120E1	78.18	56.73	6.38	9.04	4.61	3.19	6.56	4.43	3.01	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	41.81	31.49	3.44	20.07	5.77	3.11	2.44	4.32	5.21	1.22
Mast cell, expanded and stimulated, donor8	11942-126A7	53.12	79.38	2.33	17.51	11.09	6.42	1.17	6.42	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	100.84	56.44	3.67	14.80	5.05	3.90	3.56	6.08	2.06	0.46
Mast cell, expanded, donor8	11941-126A6	100.09	44.18	4.69	13.72	6.19	5.02	3.18	4.52	2.51	0.67
Melanocyte - dark, donor1	11502-119F8	679.37	98.01	14.92	7.76	9.15	6.07	3.48	7.76	2.19	4.18
Melanocyte - dark, donor2	11582-120F7	445.06	83.06	7.61	7.61	11.42	6.58	3.81	2.77	3.11	2.77
Melanocyte - dark, donor3	11663-122F7	253.76	64.33	3.40	14.20	2.90	3.91	4.93	3.26	4.06	1.74
Melanocyte - light, donor1	11274-116H5	395.63	133.99	6.11	26.09	9.87	15.51	3.53	9.17	5.17	2.12
Melanocyte - light, donor2	11351-117H1	464.76	141.95	6.82	13.65	22.52	15.70	6.14	7.51	2.05	1.36
Melanocyte - light, donor3	11423-118G1	434.48	83.25	0.87	13.01	10.41	9.54	6.94	9.54	1.73	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	266.56	59.46	2.60	7.50	7.18	5.10	4.48	2.19	2.39	2.29
Melanocyte, donor2 (MC+2)	12739-135I3	252.27	79.61	8.07	13.72	8.88	3.50	2.42	5.92	1.88	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	318.75	80.62	5.36	3.75	5.09	4.29	5.36	1.07	1.61	1.34
Meningeal Cells, donor1	11493-119E8	812.10	164.01	20.10	17.62	5.09	7.20	12.03	5.33	3.23	3.23
Meningeal Cells, donor2	11573-120E7	886.02	128.96	16.73	18.93	3.52	10.56	18.93	6.60	2.20	1.32
Meningeal Cells, donor3	11654-122E7	568.39	138.96	14.34	15.00	5.46	7.99	6.60	9.05	3.59	3.67
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	422.89	65.30	9.70	20.53	5.13	2.57	3.99	5.99	5.13	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	169.87	51.02	5.33	9.06	2.21	3.62	0.81	2.42	2.52	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1600.65	345.63	81.48	17.08	17.08	23.65	9.20	2.63	5.26	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	665.85	108.58	13.08	26.16	7.85	9.16	11.77	1.31	3.92	6.54
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	343.73	103.34	5.02	25.12	10.76	10.05	3.59	5.74	3.59	4.31
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	822.30	96.14	12.07	13.76	20.75	17.36	1.27	2.54	2.33	5.08
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	1145.53	110.08	12.57	12.57	42.22	31.16	5.03	3.02	2.01	5.03
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	551.14	94.05	6.59	26.81	5.93	7.69	5.27	5.05	4.40	2.42
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	446.39	90.59	2.92	27.03	9.50	7.31	8.77	6.58	2.92	5.11
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	487.57	81.43	6.34	23.73	9.41	7.16	6.55	4.91	4.30	2.86
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	196.13	50.28	10.25	5.82	3.19	3.46	5.12	1.80	0.97	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	668.73	109.66	15.24	6.32	3.72	7.81	4.09	3.35	4.46	2.97
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	282.49	42.76	17.50	3.55	5.66	4.87	3.68	2.89	1.58	2.37
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	233.53	69.14	8.61	1.78	2.37	2.67	5.64	1.19	0.59	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	212.53	60.72	11.68	4.67	4.67	2.34	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	782.57	67.24	12.17	23.69	11.53	5.76	8.97	8.97	6.40	5.12
Mesenchymal stem cells - adipose, donor0	11217-116B2	266.54	98.89	5.32	28.36	2.13	1.77	6.73	6.38	3.54	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	281.76	40.34	11.88	1.25	2.81	1.56	4.07	2.81	1.25	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	443.40	71.12	7.26	18.14	7.26	5.08	2.18	9.43	3.63	1.45
Mesothelial Cells, donor1	11247-116E5	122.51	17.50	5.04	3.71	1.59	1.86	2.12	2.65	0.80	1.59
Mesothelial Cells, donor2	12156-128G5	206.69	51.05	6.01	9.01	4.00	2.00	2.00	3.00	2.00	1.50
Mesothelial Cells, donor3	11402-118D7	267.23	33.89	6.21	5.13	7.15	6.07	3.54	2.82	1.30	2.10
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	275.47	176.89	9.45	62.11	2.70	0.00	8.10	8.10	12.15	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	122.64	35.71	2.71	16.75	4.19	3.20	3.45	2.46	3.94	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	98.05	33.27	1.77	20.02	3.83	0.29	4.71	2.94	11.19	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	190.14	110.63	0.00	44.94	3.46	0.00	13.83	10.37	13.83	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	85.55	24.18	1.55	9.92	4.03	2.79	1.86	2.48	3.41	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	70.94	31.74	1.45	14.94	2.28	1.87	1.87	1.87	8.09	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	136.65	111.17	0.00	37.06	0.00	6.95	4.63	9.26	6.95	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	109.86	29.03	1.50	16.77	4.75	2.00	4.25	2.75	5.76	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	110.32	40.03	1.40	21.41	0.47	0.47	2.33	1.86	7.91	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	233.59	0.00	77.86	0.00	0.00	19.47	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	104.05	26.21	2.64	14.63	4.27	3.05	3.45	1.42	3.86	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	91.47	30.89	1.58	15.84	3.56	0.40	0.79	1.58	5.94	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	213.79	256.54	0.00	68.41	0.00	0.00	8.55	42.76	17.10	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	98.23	32.74	2.65	13.27	5.31	1.77	1.77	1.77	3.54	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	80.55	32.67	1.14	18.24	4.94	1.90	1.90	1.52	4.18	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	140.80	78.95	2.63	27.63	2.63	0.00	5.26	7.90	11.84	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	82.13	27.16	1.91	9.97	2.76	2.55	2.97	3.40	3.40	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	58.93	23.02	1.84	16.57	4.60	0.92	0.92	3.68	3.68	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	84.35	24.44	0.89	14.01	4.17	2.38	3.87	1.49	2.38	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	100.60	63.71	1.68	11.74	3.35	1.68	3.35	3.35	6.71	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	271.59	271.59	0.00	33.95	0.00	0.00	0.00	67.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	84.55	28.60	1.51	10.04	4.01	2.51	2.51	2.01	2.26	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	73.68	27.57	1.66	19.25	4.04	0.95	1.43	2.14	5.47	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	90.12	44.23	0.55	20.46	0.00	0.55	4.42	1.66	5.53	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	89.80	24.18	1.61	9.90	3.45	2.30	2.07	1.15	4.84	1.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	75.51	25.66	1.89	18.51	2.73	0.84	1.68	1.68	6.10	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	84.59	19.77	1.02	13.25	1.63	1.83	2.04	1.43	3.87	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	89.03	21.24	2.15	9.65	2.57	2.36	2.15	2.36	2.15	1.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	83.36	26.01	1.78	22.45	1.33	1.56	0.89	2.00	6.67	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	165.10	0.00	82.55	0.00	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	68.11	18.18	0.88	7.67	2.19	2.19	1.10	0.66	1.97	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	85.68	31.94	1.52	17.74	0.51	0.00	3.04	3.55	8.11	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	140.84	82.85	0.00	24.85	1.66	1.66	1.66	6.63	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	100.29	23.37	0.82	8.97	1.36	1.90	1.09	1.36	2.72	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	72.34	22.64	0.88	20.59	1.76	0.59	0.59	1.76	4.71	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	111.21	76.32	0.00	15.26	8.72	4.36	5.45	5.45	5.45	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	110.53	24.99	1.44	12.01	1.44	0.48	3.84	2.40	5.29	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	72.44	19.21	1.20	16.01	3.60	2.40	1.60	1.60	4.40	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	205.68	69.93	0.00	27.42	1.37	0.00	1.37	6.86	9.60	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	127.65	22.53	1.00	10.01	2.00	3.00	1.50	3.50	5.01	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	226.27	46.89	0.00	24.46	2.04	0.00	4.08	2.04	14.27	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	98.53	25.40	1.75	7.44	3.07	1.31	1.31	1.31	2.63	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	139.06	43.04	1.10	20.97	2.21	1.10	2.21	0.00	9.93	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	181.87	52.51	1.28	23.69	1.28	1.28	1.92	2.56	5.76	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	113.30	20.08	0.50	11.65	2.48	2.23	1.74	0.99	3.72	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	110.65	28.53	0.70	16.70	0.70	0.00	4.18	1.39	3.48	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	209.94	61.88	0.00	24.31	0.00	0.00	4.42	4.42	13.26	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	117.95	22.91	0.68	11.28	2.74	2.39	2.39	1.37	2.74	2.05
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	121.22	28.44	0.88	14.44	0.88	0.44	2.19	0.44	5.69	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	162.28	40.13	1.78	15.27	1.78	0.71	4.62	3.20	4.97	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	100.16	19.08	0.56	8.70	3.37	1.40	1.96	1.68	4.49	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	92.69	19.53	0.42	14.13	0.42	1.25	2.49	1.25	4.16	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	179.49	37.30	1.17	22.14	1.17	0.58	8.74	2.91	6.41	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	106.19	17.19	0.90	15.69	3.62	1.21	2.11	0.60	3.62	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	90.99	22.54	0.42	11.27	2.09	2.09	0.42	1.25	2.50	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	209.35	86.63	7.22	21.66	7.22	0.00	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	91.43	20.32	0.92	9.24	4.62	0.92	4.62	1.85	2.77	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	114.96	30.73	1.14	10.24	2.28	2.28	1.14	1.71	3.41	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	102.81	17.69	1.24	13.27	1.38	0.69	4.28	1.80	4.28	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	93.03	15.81	1.30	9.33	2.33	1.30	2.85	1.30	3.63	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	134.27	27.03	0.43	12.44	1.29	1.29	2.57	0.86	3.43	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	140.38	28.58	1.27	11.43	0.64	1.27	9.53	1.27	5.72	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	87.01	16.28	1.33	8.27	1.33	0.53	2.67	1.07	2.94	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	77.53	11.37	1.80	13.77	0.90	1.20	2.69	0.60	2.69	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	62.01	10.31	1.55	7.49	0.57	0.42	2.54	0.85	1.41	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	89.50	12.10	2.55	9.24	2.55	1.91	1.91	0.96	1.91	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	113.22	19.68	1.33	14.59	2.87	0.66	3.54	1.77	5.53	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	103.90	19.72	0.38	11.38	1.14	1.14	3.03	1.90	3.79	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	71.59	13.07	0.28	6.53	1.99	1.14	1.99	0.85	2.56	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	111.84	20.65	1.97	14.26	2.70	2.95	2.46	1.23	2.95	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	73.64	11.08	1.96	7.82	0.00	0.00	3.26	1.96	4.56	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	57.34	10.58	0.88	4.12	2.06	0.88	1.18	1.18	2.06	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	75.54	14.99	1.15	12.69	1.44	1.73	3.17	2.02	5.19	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.98	18.55	2.06	8.66	2.06	0.00	2.89	2.89	2.06	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	38.41	8.04	0.30	3.28	1.49	0.30	3.87	0.60	1.19	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	71.57	18.83	3.77	0.00	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	103.37	19.60	0.00	1.78	3.56	1.78	3.56	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	163.30	33.51	1.31	3.29	4.93	4.27	3.94	1.64	0.99	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	122.03	21.04	6.31	6.31	9.47	4.21	5.26	1.05	3.16	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	69.78	30.84	2.17	6.13	1.58	0.79	2.37	1.78	1.58	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	81.02	35.39	2.79	10.24	2.79	2.79	4.66	0.00	6.52	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	149.46	36.43	0.38	4.88	6.01	2.63	3.76	2.25	2.63	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	104.67	32.76	0.27	14.65	4.79	3.46	1.86	1.86	4.26	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	88.11	25.56	1.58	0.68	1.24	0.90	2.60	1.24	0.34	0.90
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	129.66	37.57	0.74	11.05	5.16	4.42	5.16	3.68	1.47	3.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	147.67	28.95	1.10	2.56	5.50	5.50	3.66	2.20	0.73	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	119.78	18.67	6.22	7.78	28.00	10.89	3.11	1.56	6.22	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	169.95	51.31	1.07	5.34	2.14	1.07	2.67	2.14	3.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	123.64	27.05	0.00	0.00	3.86	3.86	7.73	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	162.60	22.22	0.00	3.03	6.06	6.06	6.06	2.02	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	139.14	36.26	2.95	7.17	6.32	2.95	5.06	1.26	3.79	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	177.05	74.91	1.36	9.53	2.72	5.45	1.36	0.00	6.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	161.49	57.86	1.27	13.35	4.45	0.64	1.27	3.18	2.54	1.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	176.54	46.16	0.81	6.48	2.43	2.43	2.43	4.86	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	208.44	46.82	0.00	7.55	9.06	13.59	9.06	1.51	10.57	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	251.25	34.26	0.00	11.42	0.00	0.00	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	159.86	45.67	6.52	16.31	0.00	0.00	0.00	0.00	3.26	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	242.38	47.52	4.75	23.76	0.00	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	451.77	37.65	0.00	25.10	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	516.83	88.54	7.54	14.87	11.20	9.05	4.31	3.45	2.80	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	955.33	64.80	14.63	7.32	17.77	18.81	7.84	1.57	0.52	4.70
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	506.62	38.05	7.34	11.35	14.02	9.34	2.67	2.00	3.34	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	593.50	27.13	4.59	10.85	13.77	5.84	7.51	3.34	2.50	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	642.49	28.90	14.26	14.26	38.79	19.58	11.41	2.09	3.61	4.94
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1621.39	143.63	9.58	25.53	7.98	11.17	7.98	3.19	3.19	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	403.89	20.40	2.72	5.44	20.40	9.52	3.40	2.04	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	527.40	95.56	31.24	25.73	18.38	3.68	5.51	9.19	5.51	16.54
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	562.93	29.72	3.35	4.60	23.86	10.04	6.28	0.42	2.09	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	504.39	22.08	5.35	6.97	14.88	6.04	8.83	1.63	1.16	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	820.41	30.54	6.76	4.32	17.29	12.70	7.84	4.32	1.35	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	1020.49	64.75	10.93	10.30	13.46	6.73	6.73	1.89	2.94	3.99
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1592.27	456.52	55.67	33.40	11.13	22.27	22.27	77.94	11.13	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	432.33	36.73	5.46	3.97	27.80	11.42	6.95	1.99	0.00	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	308.29	10.01	6.50	2.17	32.75	10.56	2.71	0.27	0.27	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	380.60	16.55	2.49	2.04	22.21	13.37	4.31	0.45	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	661.53	24.66	3.27	6.37	15.02	12.57	4.90	1.63	2.94	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	558.98	36.45	9.48	6.01	13.67	6.56	5.47	1.46	1.09	2.92
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	374.49	27.05	3.71	1.59	13.26	14.32	4.77	1.06	1.59	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	363.79	21.61	3.60	7.20	15.01	7.80	7.20	1.20	2.40	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	339.99	18.38	25.60	4.27	37.74	14.77	5.25	1.64	1.31	2.30
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	445.59	16.42	3.42	2.28	11.55	6.99	5.85	1.14	1.14	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	734.81	39.33	16.05	4.94	8.29	7.76	5.29	2.29	1.94	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	252.46	16.17	4.92	2.11	16.17	6.33	0.70	0.70	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	319.04	13.33	7.82	2.30	21.61	6.90	4.14	0.92	0.92	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	387.86	25.39	6.11	4.50	17.35	8.35	3.21	1.61	0.64	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	310.05	19.31	23.80	5.17	50.35	17.59	4.14	1.03	2.07	6.90
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1069.53	121.37	88.50	58.15	15.17	5.06	7.59	17.70	7.59	12.64
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	610.87	36.98	11.81	6.46	7.57	4.90	5.35	2.23	0.89	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	343.79	17.36	6.35	5.93	22.02	6.35	3.39	0.42	1.69	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	274.38	14.00	4.75	2.61	16.14	6.17	4.27	0.71	0.95	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	399.63	22.32	4.29	3.86	14.59	7.73	4.29	0.86	1.72	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	758.33	315.97	45.14	99.31	27.08	0.00	18.06	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	372.54	24.33	4.67	4.33	11.00	4.00	3.33	1.33	1.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	735.81	31.56	5.41	7.21	7.66	3.16	5.41	3.16	3.61	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	234.11	17.46	1.98	5.95	11.11	7.14	1.19	1.19	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	284.17	21.36	3.71	9.29	7.43	3.71	2.79	0.93	1.86	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	276.97	16.27	6.43	6.43	19.68	7.57	2.65	1.14	1.14	3.03
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	330.45	24.77	6.19	8.15	14.34	9.78	4.89	0.98	1.63	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	325.10	25.71	3.92	4.36	6.10	3.49	4.79	0.44	2.18	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	660.79	42.06	6.33	9.95	4.07	1.81	7.24	2.26	0.90	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	234.59	15.87	4.41	3.53	14.99	7.94	3.53	0.00	0.88	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	267.27	21.28	1.33	5.32	19.95	5.98	1.99	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	341.77	28.77	4.96	5.46	17.86	9.92	2.98	0.00	0.50	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	357.56	21.44	8.04	3.83	8.80	4.59	6.51	0.38	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	189.33	15.12	7.26	4.23	10.59	3.93	6.05	1.51	1.51	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	578.20	38.24	7.96	11.49	7.96	4.86	3.98	1.33	3.54	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	250.73	19.65	4.74	6.78	18.30	4.74	0.68	1.36	2.03	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	383.21	137.96	40.88	15.33	15.33	10.22	5.11	10.22	5.11	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	249.97	17.07	3.66	2.44	15.24	5.49	4.88	1.22	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	299.00	18.88	3.78	6.92	7.55	5.98	4.41	0.63	0.94	1.89
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	398.29	18.46	6.05	4.84	12.41	5.75	8.17	1.82	2.42	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	272.94	17.41	3.16	3.96	22.15	7.91	4.75	1.58	1.58	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	272.07	41.94	26.07	13.60	41.94	14.74	4.53	2.27	3.40	6.80
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	328.76	91.04	20.23	10.12	5.06	10.12	0.00	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	236.53	61.49	7.33	14.66	5.09	4.72	2.86	4.72	2.24	1.37
Myoblast, donor2	11322-117D8	400.84	83.24	11.12	22.44	12.27	15.73	7.10	3.45	3.84	2.69
Myoblast, donor3	11398-118D3	516.93	80.21	9.59	14.63	6.89	7.90	6.05	2.86	2.35	3.70
NK T cell leukemia cell line:KHYG-1	10777-110G3	120.69	26.85	1.46	2.19	2.19	1.46	4.67	0.44	0.58	0.73
Natural Killer Cells, donor1	11230-116C6	23.68	7.38	4.31	0.00	0.62	0.92	1.54	0.31	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	60.31	19.60	6.33	0.60	1.51	1.51	4.52	0.30	0.30	0.90
Natural Killer Cells, donor3	11387-118C1	18.22	9.75	2.21	0.00	1.29	0.55	2.21	0.55	0.00	0.00
Neural stem cells, donor1	11275-116H6	630.43	128.12	22.50	29.76	52.63	47.18	13.43	7.26	7.62	7.62
Neural stem cells, donor2	11352-117H2	1455.79	65.47	23.11	25.03	38.51	61.62	17.33	1.93	3.85	3.85
Neurons, donor1	11494-119E9	1960.60	47.79	21.62	34.14	54.62	31.86	23.90	4.55	13.65	17.07
Neurons, donor2	11574-120E8	1661.13	47.56	29.94	17.39	22.90	16.07	43.81	3.52	12.33	8.59
Neurons, donor3	11655-122E8	1745.46	35.35	34.53	20.55	141.41	43.57	45.22	3.29	12.33	8.22
Neutrophils, donor1	11233-116C9	15.78	4.64	1.86	0.00	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	2.90	0.00	2.90	2.90	5.80	8.70	0.00	0.00
Neutrophils, donor3	11390-118C4	17.71	2.44	1.22	1.22	1.83	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	206.01	38.59	16.74	4.87	2.49	2.49	5.34	2.14	0.95	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	440.22	49.17	13.35	3.58	12.37	13.02	6.84	2.28	0.65	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	320.48	47.53	7.82	7.02	8.62	2.21	6.22	1.80	0.60	0.80
Olfactory epithelial cells, donor1	11933-125I7	754.88	30.97	14.04	4.68	35.51	12.66	4.40	1.65	1.51	2.75
Olfactory epithelial cells, donor2	11934-125I8	905.96	48.34	13.61	8.11	67.02	32.57	4.34	3.18	1.74	5.36
Olfactory epithelial cells, donor3	11935-125I9	790.45	45.63	13.17	3.63	34.62	12.37	3.86	2.27	1.48	2.50
Olfactory epithelial cells, donor4	11936-126A1	675.06	37.69	17.43	3.99	27.27	10.42	3.90	2.14	1.17	2.82
Oligodendrocyte - precursors, donor1	11496-119F2	417.66	37.31	8.43	9.03	3.61	4.21	4.81	2.41	4.81	1.20
Osteoblast - differentiated, donor1	11276-116H7	301.60	79.33	15.31	19.78	12.97	9.15	5.32	2.13	4.04	0.43
Osteoblast - differentiated, donor2	11353-117H3	256.06	93.74	6.86	18.29	18.29	20.58	6.86	5.72	6.86	16.00
Osteoblast - differentiated, donor3	11425-118G3	330.22	112.35	8.69	21.72	11.17	9.31	12.41	8.69	1.86	1.24
Osteoblast, donor1	11277-116H8	957.06	163.39	15.83	40.26	15.83	15.05	10.36	9.97	10.55	5.08
Osteoblast, donor2	11354-117H4	714.96	120.10	18.26	29.50	18.96	18.26	5.62	5.62	5.62	1.40
Osteoblast, donor3	11426-118G4	693.86	113.39	10.84	31.10	9.95	10.84	5.33	7.29	5.51	6.04
Pancreatic stromal cells, donor1	11249-116E7	386.89	88.36	11.03	12.21	12.38	7.83	4.46	5.39	1.94	1.68
Pericytes, donor1	11491-119E6	871.22	122.06	21.81	6.12	13.02	9.90	8.68	3.12	1.56	3.12
Pericytes, donor2	11571-120E5	748.37	109.56	13.58	10.19	14.03	10.19	14.49	4.53	1.58	2.94
Pericytes, donor3	11652-122E5	547.08	61.03	9.56	10.58	6.31	8.54	4.48	4.27	1.83	3.87
Perineurial Cells, donor1	11499-119F5	534.93	65.55	7.69	4.86	5.99	5.09	6.10	3.28	1.70	2.49
Perineurial Cells, donor2	11579-120F4	396.47	92.93	10.40	12.97	7.73	5.15	3.31	6.53	3.13	1.84
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	9.24	3.82	1.27	0.96	0.00	0.64	0.96	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.37	1.96	0.24	0.00	0.00	0.73	0.73	0.00	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	29.77	9.58	3.11	0.91	1.29	0.91	2.98	0.13	0.39	0.26
Placental Epithelial Cells, donor1	11278-116H9	320.72	78.92	10.76	8.37	8.37	3.11	5.74	5.02	0.96	1.67
Placental Epithelial Cells, donor2	11355-117H5	716.34	150.81	21.07	3.33	14.42	8.87	4.44	4.44	3.33	3.33
Placental Epithelial Cells, donor3	11427-118G5	516.54	78.14	19.83	6.09	9.42	8.64	12.96	3.14	0.79	2.16
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	351.90	72.47	10.76	10.76	31.96	18.04	1.90	1.58	3.16	3.16
Preadipocyte - breast, donor1	11467-119B9	243.68	73.35	10.50	5.25	8.82	7.50	2.25	3.00	1.13	1.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	265.88	26.24	8.35	5.61	3.39	5.22	2.22	1.96	2.22	1.83
Preadipocyte - breast, donor2	11328-117E5	374.87	70.70	13.96	12.38	15.31	12.38	4.05	5.18	3.83	2.25
Preadipocyte - omental, donor1	11468-119C1	231.34	64.68	14.28	7.25	8.10	6.50	2.77	3.73	1.17	1.92
Preadipocyte - omental, donor2	11329-117E6	409.85	75.51	18.77	7.86	6.98	17.46	3.06	5.24	1.75	3.06
Preadipocyte - omental, donor3	11403-118D8	379.04	53.29	12.03	13.32	14.75	14.32	4.58	4.44	3.87	2.86
Preadipocyte - perirenal, donor1	11469-119C2	301.19	55.12	4.92	7.87	7.87	3.94	3.94	4.92	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	443.78	164.00	14.43	36.24	8.91	9.83	9.21	8.60	7.99	2.76
Preadipocyte - subcutaneous, donor2	11356-117H6	351.32	86.94	9.03	27.27	17.88	16.29	6.20	5.84	6.55	3.90
Preadipocyte - subcutaneous, donor3	11428-118G6	409.02	113.75	10.90	33.55	16.86	12.77	5.96	5.96	9.20	2.89
Preadipocyte - visceral, donor1	11280-116I2	325.36	92.22	11.18	17.98	12.30	12.20	4.47	5.68	4.84	1.86
Preadipocyte - visceral, donor2	11357-117H7	311.08	113.66	10.58	27.15	11.50	17.03	6.90	4.60	6.90	0.92
Preadipocyte - visceral, donor3	11429-118G7	258.51	85.06	7.31	23.93	15.46	7.73	5.64	5.85	3.76	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	384.52	44.65	12.22	6.49	14.18	11.01	2.41	2.87	1.66	2.11
Prostate Epithelial Cells, donor2	11331-117E8	144.76	25.19	4.60	5.28	6.09	7.85	3.11	1.62	0.95	1.35
Prostate Epithelial Cells, donor3	11404-118D9	201.96	32.03	9.55	13.84	9.61	8.57	5.63	2.45	3.12	1.41
Prostate Stromal Cells, donor1	11254-116F3	297.28	66.63	6.38	10.59	7.06	5.35	2.51	3.53	1.59	2.05
Prostate Stromal Cells, donor2	11332-117E9	381.37	90.19	5.92	21.34	12.55	10.94	4.30	4.84	3.59	2.51
Prostate Stromal Cells, donor3	11405-118E1	301.46	44.53	6.36	10.95	10.11	10.74	3.65	3.13	2.61	1.88
Renal Cortical Epithelial Cells, donor1	11516-119H4	456.59	82.12	6.57	5.84	1.82	3.65	7.66	4.74	2.92	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	209.46	46.44	6.58	10.67	2.08	2.63	4.92	3.40	1.52	1.73
Renal Epithelial Cells, donor1	11517-119H5	697.95	135.94	10.14	13.70	4.06	5.07	15.22	6.09	4.57	1.52
Renal Epithelial Cells, donor2	11597-120H4	481.56	98.87	4.27	6.40	5.69	8.54	11.38	2.85	2.85	2.85
Renal Epithelial Cells, donor3	11678-122H4	271.23	70.72	6.56	8.36	4.66	3.60	5.93	4.34	2.01	1.27
Renal Glomerular Endothelial Cells, donor1	11514-119H2	546.04	89.87	9.53	11.57	9.53	11.57	15.66	10.21	0.68	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	397.55	60.37	11.59	9.03	10.51	5.93	10.24	5.53	0.40	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	456.45	68.38	8.21	7.55	13.76	6.88	7.33	2.00	1.55	3.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	845.78	136.42	13.97	21.96	13.31	8.65	12.64	7.99	6.65	2.66
Renal Mesangial Cells, donor1	11518-119H6	683.81	95.96	10.56	14.75	5.06	6.38	6.16	4.62	2.42	3.52
Renal Mesangial Cells, donor2	11598-120H5	759.28	101.57	7.52	10.66	6.90	7.52	10.03	4.39	2.51	5.02
Renal Mesangial Cells, donor3	11679-122H5	746.24	95.71	6.94	14.70	9.15	4.44	12.48	4.16	2.22	4.99
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	241.85	59.05	5.91	5.91	0.81	2.95	3.76	5.10	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	183.86	43.01	2.95	8.86	4.64	4.64	6.75	1.69	1.27	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	479.80	73.47	7.91	7.14	6.75	7.33	11.38	4.44	3.09	3.28
Retinal Pigment Epithelial Cells, donor0	11215-116A9	175.79	26.97	3.89	2.33	1.81	1.56	3.89	2.85	1.04	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	326.88	46.33	10.52	3.13	5.97	5.97	7.11	0.85	1.71	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	545.44	50.43	11.32	9.26	6.17	9.26	7.20	2.06	3.09	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	127.46	57.21	9.79	4.01	2.51	2.76	3.26	1.25	2.01	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	1111.72	78.85	23.92	11.36	23.92	16.44	3.34	5.75	2.67	3.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	146.52	74.15	4.47	21.44	6.25	5.36	1.79	4.47	3.57	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	130.44	40.73	20.91	15.41	21.46	12.66	4.95	2.20	0.00	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	177.50	57.43	17.40	17.40	8.70	5.80	5.80	5.22	4.06	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	237.56	69.95	12.48	9.23	5.20	4.03	9.36	2.08	1.17	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	283.02	53.33	11.82	7.35	7.94	5.16	11.52	1.99	0.99	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	250.29	59.23	12.38	4.80	4.35	3.79	8.25	2.79	2.01	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	296.09	65.12	16.75	10.05	4.71	4.34	11.29	4.96	1.12	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	300.34	61.89	11.77	7.34	7.69	6.76	11.89	3.73	1.28	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	345.08	48.77	13.87	7.86	9.94	6.01	11.56	3.00	2.08	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	313.66	52.16	13.01	4.52	4.93	2.46	13.14	1.92	1.10	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	285.45	61.27	9.98	6.96	9.83	8.17	10.74	4.08	1.97	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	267.71	59.31	7.88	6.09	2.87	2.33	6.45	2.33	1.08	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	311.59	55.95	12.48	8.61	6.60	4.30	11.76	2.30	1.00	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	286.96	60.20	11.05	6.12	5.58	4.61	9.34	3.22	1.29	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	301.15	50.23	11.95	3.98	11.06	6.20	8.85	2.43	0.89	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	329.01	57.54	12.43	5.35	3.44	1.91	13.00	2.49	0.19	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	306.60	54.03	12.86	7.36	5.03	3.73	10.71	3.63	2.05	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	230.19	51.86	15.22	4.70	8.83	9.21	6.95	3.01	1.50	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	339.99	69.01	14.33	6.90	7.56	2.79	11.94	4.25	0.80	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	282.48	52.95	12.26	6.13	4.96	5.35	11.29	2.73	1.75	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	324.25	49.08	12.60	6.87	14.51	10.50	6.68	2.86	1.53	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	293.36	63.86	13.03	8.54	6.73	3.84	13.46	2.99	0.64	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	297.68	55.50	12.33	7.85	10.65	6.45	9.25	3.36	1.68	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	289.67	46.48	13.16	6.67	4.44	4.27	9.74	2.22	1.54	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	307.04	59.08	16.05	9.12	6.20	2.37	11.85	3.46	1.46	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	308.42	54.08	12.14	5.40	6.74	5.89	9.81	2.58	2.08	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	308.94	54.53	11.28	6.31	7.12	6.31	10.07	2.42	2.01	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	349.09	69.11	13.92	9.20	8.26	3.77	12.74	1.65	0.71	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	261.91	51.59	11.11	8.53	7.54	5.16	9.92	3.17	1.19	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	308.21	52.85	9.59	5.14	5.85	4.44	7.72	2.57	1.40	2.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	337.37	59.10	14.10	6.64	6.43	3.11	11.61	2.49	0.83	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	254.17	77.87	14.38	7.30	8.63	7.74	12.39	3.54	1.77	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	302.26	46.16	11.70	3.13	8.77	5.64	7.52	2.51	0.84	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	362.17	66.22	14.54	7.67	7.81	4.44	14.94	2.69	0.67	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	314.02	66.07	12.60	5.79	6.13	2.38	10.90	4.09	1.02	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	288.61	54.37	14.85	7.33	7.33	7.13	10.41	2.89	1.54	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	346.45	70.49	16.16	8.60	7.05	5.16	12.72	3.61	1.38	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	305.75	69.41	12.35	5.76	5.76	2.74	13.31	4.25	1.37	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	321.28	56.97	15.10	6.73	5.58	6.57	7.88	2.13	1.97	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	351.77	68.51	13.46	8.69	7.16	3.41	14.49	3.07	0.68	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	311.75	56.52	17.16	7.55	7.55	8.58	11.69	4.44	1.92	3.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	388.10	56.24	11.46	4.80	3.47	4.53	10.13	3.20	1.07	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	218.18	53.65	11.75	14.38	5.39	3.18	14.10	3.59	1.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	282.63	60.00	10.95	10.00	8.81	6.19	11.91	4.76	3.57	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	451.25	62.07	18.14	11.29	6.05	4.64	14.51	5.04	2.62	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	283.84	84.38	15.44	13.18	10.45	7.72	9.70	4.90	1.51	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	256.43	79.65	9.78	23.41	18.17	12.58	8.73	10.13	3.84	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	199.76	78.88	9.07	14.81	5.14	4.53	8.46	5.74	4.53	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	314.78	102.19	12.97	22.89	16.03	7.34	11.63	5.02	1.96	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	191.69	82.67	12.95	20.38	4.95	2.77	4.95	5.53	3.06	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	296.91	97.96	13.99	23.73	9.73	4.26	10.95	4.26	2.43	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	333.65	98.26	12.36	21.10	11.45	6.93	9.34	3.01	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	275.27	77.36	15.61	29.40	25.56	16.29	8.60	7.01	4.07	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	324.10	92.56	15.58	29.65	12.28	7.79	8.69	4.79	5.99	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	149.60	66.00	11.22	12.87	24.80	10.27	6.02	2.83	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	220.49	64.89	7.90	22.63	31.59	20.70	7.47	3.84	3.63	5.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	257.22	82.93	12.02	20.43	15.63	19.23	7.21	4.21	2.40	4.21
Schwann Cells, donor1	11498-119F4	1000.16	114.54	13.35	17.87	14.11	10.53	26.89	5.45	1.88	4.89
Schwann Cells, donor2	11578-120F3	486.55	61.24	3.40	3.40	17.01	10.21	3.40	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	744.88	67.04	7.23	5.48	17.75	13.36	11.17	1.53	1.75	6.13
Sebocyte, donor1	11220-116B5	373.58	36.15	22.46	9.86	4.93	3.29	6.57	7.12	2.19	0.55
Sebocyte, donor2	11301-117B5	254.59	23.90	12.87	2.30	3.22	11.95	4.14	1.84	2.30	1.84
Sebocyte, donor3	11378-118B1	349.36	30.92	12.57	5.15	4.12	6.39	7.01	2.89	1.86	2.89
Sertoli Cells, donor1	11255-116F4	336.29	64.61	19.88	14.91	13.25	14.91	0.00	4.97	0.00	1.66
Sertoli Cells, donor2	11333-117F1	290.91	98.85	22.59	11.30	22.59	19.77	2.82	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	466.99	78.39	23.49	12.40	20.06	10.21	9.59	5.01	2.46	2.02
Skeletal Muscle Cells, donor2	11358-117H8	370.10	122.88	7.95	25.30	13.01	13.01	5.06	7.23	5.06	2.89
Skeletal Muscle Cells, donor3	11430-118G8	998.23	94.47	24.25	35.11	10.87	11.70	24.25	18.39	8.36	5.02
Skeletal Muscle Cells, donor4	11451-119A2	398.55	66.61	6.44	17.28	10.68	6.44	5.81	5.03	2.83	2.83
Skeletal Muscle Cells, donor5	11455-119A6	432.70	57.53	6.54	19.77	11.89	8.03	4.91	5.65	2.68	2.53
Skeletal Muscle Cells, donor6	11459-119B1	326.73	60.33	6.00	18.01	11.23	6.77	7.70	4.62	2.15	1.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	623.35	68.30	15.37	13.23	9.58	9.95	5.42	6.55	2.65	4.41
Skeletal Muscle Satellite Cells, donor2	11321-117D7	688.62	61.21	10.70	14.27	15.98	15.27	9.70	3.00	3.85	5.99
Skeletal Muscle Satellite Cells, donor3	11397-118D2	479.68	65.28	7.24	17.46	11.01	9.13	6.45	5.46	4.66	3.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	537.27	95.29	14.07	20.47	13.14	12.05	4.13	5.06	4.47	2.44
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	643.43	53.56	12.30	11.58	7.24	9.41	13.75	5.07	6.51	5.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	749.78	97.70	10.73	36.33	14.59	13.90	10.46	7.16	3.16	5.78
Skin - palm, donor1	10286-104F7	314.27	120.87	8.06	5.37	18.80	5.37	21.49	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	182.21	31.71	4.04	7.06	13.98	8.51	1.73	2.02	1.01	1.01
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	147.22	14.72	3.27	3.27	16.36	7.36	1.64	0.00	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	313.66	43.49	6.36	11.17	22.46	6.49	2.60	2.86	3.38	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	181.68	52.68	9.73	19.18	10.29	5.84	1.95	5.00	1.81	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	338.56	42.06	7.88	22.65	6.19	6.75	5.34	5.20	2.67	1.97
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	265.15	27.07	8.88	8.46	6.77	5.92	1.69	2.11	1.90	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	365.83	75.70	13.42	45.27	6.67	7.35	6.37	8.32	5.47	2.55
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	364.44	87.02	10.80	23.14	11.42	8.64	8.64	3.39	3.39	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	97.16	18.68	5.78	8.23	4.00	2.22	2.00	2.00	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	228.66	59.37	7.64	14.70	2.94	2.94	4.11	4.70	2.35	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	426.07	79.56	17.24	14.59	3.31	3.09	3.54	5.30	1.10	3.09
Smooth Muscle Cells - Aortic, donor2	11360-117I1	239.02	67.73	6.30	11.03	4.33	6.30	5.91	5.12	1.58	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	253.40	80.35	9.27	17.00	0.77	3.86	4.64	1.55	4.64	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	317.24	50.04	10.01	3.00	6.00	2.00	7.01	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	418.00	72.79	13.84	14.77	10.78	9.98	8.65	7.98	2.53	1.86
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	176.66	51.65	7.98	10.64	13.74	5.54	6.43	3.32	2.88	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	118.17	21.77	1.54	7.94	2.18	4.61	2.82	0.77	0.90	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	390.71	81.07	6.19	4.23	4.88	4.23	2.93	4.23	0.98	2.28
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	442.10	57.88	7.68	5.32	5.02	8.86	4.43	3.84	1.48	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	283.45	36.30	5.55	4.13	4.27	2.56	4.27	2.70	1.28	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	585.79	99.88	7.32	13.01	4.39	4.88	4.72	2.60	3.74	2.60
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	428.64	98.03	11.26	9.74	12.79	3.04	7.31	2.74	1.22	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	280.60	76.27	17.68	16.16	4.80	5.30	7.32	7.58	2.53	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	201.98	55.09	6.12	12.24	6.12	0.00	18.36	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	309.94	75.34	16.69	13.35	10.01	10.01	9.06	5.25	2.38	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	242.15	34.07	5.60	4.72	2.51	2.06	1.33	2.36	1.18	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	287.34	34.01	7.96	2.58	9.26	8.39	3.66	1.08	1.08	2.15
Smooth Muscle Cells - Colonic, donor3	11396-118D1	297.14	36.11	6.72	3.25	7.56	6.82	4.30	2.41	0.73	2.41
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	254.91	60.32	9.74	16.71	6.65	6.96	5.41	4.95	2.63	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	202.64	68.98	3.23	16.17	3.23	7.55	6.47	4.31	2.16	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	124.92	38.25	5.08	9.86	2.69	2.99	2.99	2.99	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	796.83	91.84	13.31	10.92	5.46	8.53	5.46	3.76	3.41	3.07
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	329.90	33.30	13.90	4.00	3.85	2.59	2.43	2.36	0.79	1.33
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	237.71	46.70	8.96	14.09	15.90	21.24	7.25	5.03	3.52	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	123.33	35.95	3.41	9.10	3.19	3.64	2.50	2.96	1.82	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	225.83	82.72	3.62	24.15	8.45	6.04	4.23	2.42	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	173.53	32.06	5.30	7.42	4.24	3.44	3.71	3.18	3.18	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	374.71	70.31	9.99	12.92	11.85	10.92	4.39	4.13	1.60	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	289.01	47.71	7.39	8.39	10.77	11.52	4.13	2.38	1.25	2.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	261.02	97.15	7.86	3.04	7.86	7.36	4.82	2.79	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	421.41	110.22	10.40	24.88	4.82	7.39	5.58	9.05	5.58	1.81
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	312.82	83.27	11.25	33.01	6.00	7.50	10.50	6.00	6.75	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2346.66	467.78	43.94	33.60	16.80	11.63	18.09	21.97	1.29	7.75
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	506.00	74.88	17.21	19.53	10.23	7.44	6.98	8.84	6.51	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	217.60	52.51	5.05	13.13	6.56	5.05	3.53	3.03	2.52	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	150.12	41.05	3.76	13.48	5.01	3.13	4.39	4.39	2.19	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	327.74	64.01	7.37	8.55	3.83	5.90	3.54	4.13	0.59	2.95
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	364.88	57.90	8.66	12.91	2.42	2.58	5.50	4.25	3.00	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	463.89	60.73	8.41	7.47	7.01	7.01	5.61	2.80	0.47	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	298.34	74.84	7.48	14.97	8.92	6.48	5.61	4.17	2.45	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	443.62	73.43	9.94	22.18	9.43	8.92	6.88	6.12	3.06	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	497.91	73.33	9.59	21.25	8.27	7.52	7.15	7.15	2.07	2.07
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	451.09	49.47	11.32	7.69	5.17	4.75	5.87	3.77	1.12	2.66
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	445.50	60.83	9.64	9.38	3.27	4.19	3.60	5.28	1.84	2.85
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	157.14	63.81	3.81	2.38	1.43	1.90	4.29	0.48	1.90	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	267.90	80.00	9.79	14.92	7.34	4.89	5.38	7.10	3.18	2.20
Smooth Muscle Cells - Uterine, donor1	11258-116F7	366.99	76.67	9.72	25.19	11.93	10.38	6.85	7.07	3.31	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	499.72	124.64	10.24	27.21	9.07	9.36	3.51	11.12	4.10	4.97
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	284.16	31.10	9.72	5.83	10.30	4.47	2.14	0.58	0.39	1.75
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	198.08	36.49	6.08	5.02	9.52	8.46	2.64	1.85	0.26	1.85
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	114.19	30.13	7.81	5.58	23.43	18.23	2.60	2.60	0.00	4.46
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	239.68	46.71	8.62	6.11	10.42	7.91	2.52	1.44	1.44	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	139.96	31.23	1.14	7.38	2.84	2.84	1.14	1.42	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	593.17	51.20	8.27	10.63	21.66	13.39	4.33	3.15	1.58	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	118.60	26.41	6.86	4.32	16.76	7.36	2.29	1.02	1.78	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	242.39	26.75	7.99	7.19	17.57	6.39	4.39	2.00	1.20	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	292.19	36.37	7.94	4.18	14.21	8.36	1.25	0.42	0.84	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	364.86	51.79	7.33	5.04	15.58	2.75	2.29	1.38	0.92	1.83
Synoviocyte, donor1	11291-117A4	556.64	71.37	13.63	16.50	19.69	17.67	6.23	4.54	3.03	3.53
Synoviocyte, donor2	11368-117I9	229.48	58.84	12.74	9.39	10.06	5.70	5.87	2.68	1.17	1.34
Synoviocyte, donor3	11440-118H9	159.07	50.27	8.94	5.14	13.40	5.14	4.02	1.34	1.12	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	1028.04	101.12	18.94	19.65	5.72	8.58	7.50	6.07	3.93	3.22
Trabecular Meshwork Cells, donor2	11612-122A1	578.76	45.59	5.95	11.89	0.00	9.91	11.89	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	865.75	69.46	16.21	18.29	7.41	8.10	13.89	5.33	3.70	4.17
Tracheal Epithelial Cells, donor1	11292-117A5	201.72	30.04	11.04	9.75	4.95	4.95	2.29	2.51	1.94	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	432.18	47.16	14.30	14.69	6.19	8.89	5.41	3.09	4.25	3.09
Tracheal Epithelial Cells, donor3	11441-118I1	250.25	35.51	8.59	17.75	7.44	5.15	6.87	2.29	1.15	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	1146.71	82.80	25.10	11.44	21.78	17.96	3.69	6.40	1.97	1.60
Urethra, donor2	10319-105A4	737.36	82.73	28.77	10.79	52.15	32.37	5.40	0.00	0.00	5.40
Urothelial Cells, donor1	11520-119H8	254.50	31.88	12.49	7.44	4.25	2.66	6.91	3.19	1.33	1.59
Urothelial Cells, donor2	11600-120H7	228.32	28.44	6.01	10.82	5.61	3.20	1.60	1.20	2.40	0.80
Urothelial Cells, donor3	11681-122H7	386.44	28.88	8.71	13.75	5.27	5.73	3.21	1.15	4.81	2.52
Urothelial cells, donor0	11216-116B1	228.02	30.09	12.93	10.92	3.57	2.45	4.01	2.67	2.23	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	209.99	16.91	26.69	0.89	2.67	1.78	2.67	0.89	0.00	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	204.43	28.59	42.89	0.00	1.43	1.43	1.43	0.00	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	174.55	15.06	40.39	1.37	2.74	2.05	3.42	0.00	0.00	5.48
Whole blood (ribopure), donor090325, donation1	12176-128I7	81.95	7.58	14.12	1.03	0.69	1.03	1.03	0.69	0.00	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	66.24	15.69	15.69	0.58	1.74	3.49	1.74	0.00	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	144.73	16.66	22.91	0.00	2.08	3.12	3.12	0.00	0.00	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	163.37	11.01	33.04	0.92	0.92	0.00	5.51	0.92	0.00	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	179.84	10.04	27.39	0.00	6.39	3.65	3.65	0.00	0.91	6.39
Wilms' tumor cell line:G-401	10809-111A8	1007.74	68.22	17.27	8.27	20.48	13.32	7.28	3.33	1.23	5.30
Wilms' tumor cell line:HFWT	10597-108E3	1643.03	125.85	6.16	20.24	13.20	4.40	7.92	5.28	0.00	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	313.12	86.31	13.69	6.98	12.01	4.75	10.06	1.96	1.12	1.96
achilles tendon, donor2	10292-104G4	419.51	55.80	14.47	4.13	24.80	4.13	6.20	2.07	0.00	10.33
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	15.55	9.43	0.00	1.78	0.76	0.51	1.02	2.04	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	5.80	0.70	0.23	0.00	1.39	0.23	0.70	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	43.68	4.51	0.59	0.36	0.47	0.71	2.26	0.24	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	105.04	3.81	3.27	0.27	3.27	1.63	6.80	0.27	0.00	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4.22	8.43	0.00	1.12	0.56	0.28	0.56	0.84	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	73.60	18.61	8.88	1.06	0.85	1.06	5.71	1.06	0.63	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	44.10	24.50	4.63	3.27	1.09	0.54	3.27	1.63	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	90.77	14.54	3.08	0.00	0.00	2.20	3.53	0.00	0.00	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	16.33	6.94	2.04	0.41	0.82	0.41	1.23	0.00	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	30.68	7.77	0.39	0.78	0.00	1.94	1.94	0.39	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4.05	2.76	0.55	0.37	0.18	0.37	1.47	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	128.72	19.50	7.80	3.90	0.00	3.90	3.90	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	57.40	17.43	2.09	0.46	0.93	0.70	4.42	0.70	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	21.23	2.85	0.52	0.52	0.52	0.52	2.07	0.00	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	12.27	5.84	0.00	0.29	0.88	0.00	2.05	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	53.45	19.06	1.39	0.93	0.46	0.00	6.51	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	328.59	69.50	6.58	6.99	9.87	10.69	6.58	3.70	3.29	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	42.97	4.60	0.92	1.53	1.53	1.23	1.53	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.15	8.11	3.84	2.13	2.56	0.43	1.71	0.43	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	47.31	12.44	2.43	1.82	0.00	0.61	3.34	1.21	0.91	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	36.83	12.76	1.20	1.20	0.48	0.48	0.96	0.72	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	85.98	13.81	1.11	2.23	2.45	1.34	4.01	0.89	0.89	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	339.55	49.03	6.34	15.34	4.00	2.33	7.00	3.00	3.34	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	48.31	92.91	0.00	3.72	0.00	0.00	3.72	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	127.31	58.76	3.01	2.26	3.39	1.88	3.39	3.01	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	28.35	31.40	1.74	0.87	0.00	0.00	1.31	0.44	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	28.12	1.87	0.00	1.87	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	377.98	43.80	29.67	5.89	6.83	3.53	13.89	1.88	2.83	2.59
adipose tissue, adult, pool1	10010-101C1	191.73	108.43	24.97	9.46	8.69	4.81	4.50	4.65	1.40	0.93
adipose, donor1	10184-103D4	884.89	65.09	29.91	32.84	216.97	65.68	8.21	8.21	3.52	15.25
adipose, donor2	10185-103D5	1845.92	47.45	10.95	30.01	73.40	47.45	30.01	6.89	9.73	4.06
adipose, donor3	10186-103D6	1769.33	52.55	16.61	24.51	58.81	36.76	26.14	4.63	6.81	4.08
adipose, donor4	10187-103D7	2680.86	64.14	11.27	14.73	52.01	24.27	54.61	6.93	7.80	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1090.54	72.28	23.36	30.62	14.84	10.26	19.89	8.52	9.47	5.05
adrenal gland, adult, pool1	10081-102A9	247.36	18.19	29.10	10.91	3.64	3.64	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	465.32	24.01	18.54	3.34	3.47	3.47	11.34	1.20	0.13	1.60
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1076.90	136.85	24.65	10.00	35.73	20.72	10.72	6.43	2.86	5.36
amniotic membrane cells, donor1	12235-129G3	148.38	47.30	15.30	1.16	2.09	2.78	4.41	0.70	0.00	0.70
amniotic membrane cells, donor2	12236-129G4	647.47	81.48	22.31	3.38	10.48	6.09	11.16	2.70	1.01	4.06
amniotic membrane cells, donor3	12237-129G5	119.61	48.61	26.81	2.06	1.18	1.77	6.48	1.18	0.00	1.18
amygdala - adult, donor10196	10167-103B5	654.56	16.60	16.60	7.11	16.60	13.04	11.86	2.37	18.97	5.93
amygdala, adult, donor10252	10151-102I7	686.57	36.90	21.70	8.92	9.73	6.49	20.68	1.42	21.70	7.30
amygdala, newborn, donor10223	10360-105E9	540.96	15.49	10.65	10.01	20.01	9.36	9.36	0.97	13.56	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	161.96	17.32	6.75	3.31	3.57	2.55	3.44	1.27	0.64	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	137.45	35.74	5.96	1.54	5.29	2.43	6.62	2.21	0.22	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	922.94	64.47	47.10	28.73	20.38	10.36	19.04	3.34	16.03	7.68
aorta, adult, pool1	10052-101G7	614.88	58.06	47.07	15.69	15.49	11.18	16.28	3.53	3.73	7.85
appendix, adult	10189-103D9	323.30	58.99	12.81	7.76	5.43	8.15	8.93	2.72	1.16	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	231.12	57.09	8.94	5.50	4.47	2.75	7.22	3.44	1.03	0.34
artery, adult	10190-103E1	131.79	51.63	23.10	9.51	6.79	8.15	6.79	2.72	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	560.78	61.42	34.19	21.87	7.68	10.00	10.14	5.94	5.50	2.17
b cell line:RPMI1788	10427-106D4	49.52	9.81	4.46	6.39	0.00	1.19	4.01	1.19	1.64	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	259.97	93.22	4.44	16.65	6.10	7.21	5.83	3.61	5.55	3.88
bile duct carcinoma cell line:HuCCT1	10432-106D9	216.23	47.73	21.83	9.33	1.79	2.38	5.06	3.27	1.49	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	21.26	3.18	2.34	0.50	1.00	0.67	1.67	0.17	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	11.74	5.59	0.00	0.56	1.12	0.56	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	393.39	96.47	30.20	12.39	9.99	8.26	8.58	4.35	3.91	2.28
blood, adult, pool1	10053-101G8	152.81	2.21	15.50	4.43	0.00	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	488.97	91.63	16.27	6.85	5.14	1.71	5.99	1.71	0.00	0.86
bone marrow, adult	10192-103E3	199.75	68.16	6.75	8.10	25.64	18.22	8.10	2.70	0.67	2.02
brain, adult, donor1	10084-102B3	380.30	29.73	15.38	18.45	17.43	5.13	21.53	1.03	19.48	10.25
brain, adult, pool1	10012-101C3	200.00	34.63	19.60	17.15	5.57	4.68	11.58	2.00	21.71	1.89
brain, fetal, pool1	10085-102B4	1856.62	32.06	13.36	26.71	40.07	48.09	64.11	2.67	21.37	8.01
breast carcinoma cell line:MCF7	10482-107A5	810.05	76.64	18.50	11.56	13.88	10.57	6.94	3.96	3.30	7.60
breast carcinoma cell line:MDA-MB-453	10419-106C5	638.84	18.72	40.94	2.62	4.62	3.87	3.74	1.50	1.62	1.37
breast, adult, donor1	10080-102A8	645.25	81.44	37.88	10.10	24.62	14.52	7.58	7.58	1.26	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	498.88	34.81	4.07	2.54	12.58	7.37	6.10	0.51	1.52	2.67
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	269.33	34.63	4.95	3.09	4.95	1.86	10.82	0.62	0.31	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	867.93	135.14	30.16	19.34	55.25	58.02	11.74	12.43	5.99	13.81
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	267.75	49.14	19.85	3.39	7.75	3.15	5.33	2.91	0.97	0.97
carcinoid cell line:NCI-H1770	10703-109H1	472.05	3.76	14.58	0.94	7.99	6.58	15.52	0.00	0.94	3.29
carcinoid cell line:NCI-H727	10735-110B6	700.14	59.39	25.92	8.53	3.83	3.39	8.64	4.05	1.20	1.20
carcinoid cell line:SK-PN-DW	10719-109I8	981.43	10.14	10.77	2.54	22.82	14.58	12.68	0.63	1.58	3.80
carcinosarcoma cell line:JHUCS-1	10642-109A3	663.32	80.65	22.09	12.78	24.75	12.51	21.29	3.73	4.26	4.26
caudate nucleus - adult, donor10196	10177-103C6	507.73	20.72	34.54	4.61	12.66	3.45	11.51	1.15	6.91	1.15
caudate nucleus, adult, donor10252	10164-103B2	634.50	22.92	20.92	2.84	9.87	8.70	15.39	1.17	9.20	4.02
caudate nucleus, adult, donor10258	10379-105H1	530.31	25.98	22.16	5.35	11.46	9.93	14.52	0.76	13.75	3.82
caudate nucleus, newborn, donor10223	10354-105E3	538.36	20.51	23.44	7.69	18.68	8.79	7.69	2.56	3.30	2.56
cerebellum - adult, donor10196	10173-103C2	620.53	87.40	171.88	2.91	14.57	2.91	29.13	5.83	0.00	8.74
cerebellum, adult, donor10252	10166-103B4	721.24	128.11	272.87	12.38	15.37	22.21	29.89	6.41	3.84	6.62
cerebellum, adult, pool1	10083-102B2	386.34	59.68	95.55	13.80	40.36	20.35	35.18	2.07	5.52	5.86
cerebellum, newborn, donor10223	10357-105E6	660.08	84.69	52.31	9.13	60.61	25.74	8.30	3.32	3.32	8.30
cerebral meninges, adult	10188-103D8	312.65	54.46	20.68	28.24	6.56	7.31	11.85	5.55	21.94	2.52
cerebrospinal fluid, donor2	10294-104G6	207.57	27.77	10.23	4.39	13.89	2.19	5.12	0.73	1.46	3.65
cervical cancer cell line:D98-AH2	10552-107I3	190.08	50.32	15.38	3.02	2.59	3.88	11.65	1.58	1.01	1.15
cervical cancer cell line:ME-180	10553-107I4	234.32	24.03	11.27	6.13	4.97	2.82	4.97	1.16	1.82	0.17
cervix, adult, pool1	10013-101C4	520.54	136.49	61.10	13.54	14.49	13.12	10.29	6.40	2.62	2.62
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	134.18	24.24	2.79	1.67	2.79	1.53	1.67	2.37	0.84	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	841.23	11.76	0.00	3.92	1.31	2.61	5.23	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	287.82	45.73	8.58	4.72	11.81	11.18	6.21	4.60	1.37	0.62
choriocarcinoma cell line:SCH	10785-110H2	338.96	35.61	10.72	2.09	5.42	4.93	4.68	1.72	0.86	2.83
choriocarcinoma cell line:T3M-3	10618-108G6	119.54	35.81	1.42	2.61	2.13	2.37	7.12	3.32	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	191.75	48.15	10.83	2.28	4.56	3.99	2.85	2.28	0.85	1.71
chorionic membrane cells, donor2	12239-129G7	705.36	82.63	9.94	15.61	24.16	15.41	3.38	5.77	2.49	8.35
chorionic membrane cells, donor3	12240-129G8	205.51	91.76	11.54	6.04	8.79	2.75	3.85	3.85	0.00	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	36.50	15.94	0.96	4.61	1.15	1.15	1.54	1.54	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	29.78	49.63	2.11	3.38	1.27	1.48	3.80	1.48	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	290.18	71.65	4.37	10.02	5.39	4.88	10.53	3.08	2.82	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	320.73	72.08	6.29	9.68	3.14	5.81	8.47	3.39	1.21	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	283.43	95.49	4.89	13.64	5.29	6.11	5.70	4.48	2.44	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	86.28	50.65	2.06	1.77	2.65	2.65	2.94	1.47	0.59	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	10.69	16.68	2.35	2.87	0.52	0.52	1.30	1.82	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	610.31	53.49	10.06	7.77	21.72	17.37	17.37	4.11	2.74	3.89
clear cell carcinoma cell line:TEN	10636-108I6	272.23	56.74	11.28	4.68	5.03	4.86	3.64	1.74	0.52	2.08
colon carcinoma cell line:CACO-2	10513-107D9	483.96	45.39	9.70	4.39	5.31	4.21	4.58	2.01	2.56	1.46
colon carcinoma cell line:COLO-320	10420-106C6	999.23	68.41	22.04	2.28	3.42	12.54	19.00	2.66	2.28	1.14
colon, adult, donor1	10082-102B1	681.89	49.98	21.42	9.52	17.85	9.52	17.85	0.00	0.00	7.14
colon, adult, pool1	10014-101C5	289.76	50.29	17.27	5.99	9.87	4.94	4.35	2.82	1.88	1.29
colon, fetal, donor1	10070-101I7	313.32	46.97	17.30	4.33	27.81	16.69	8.65	3.71	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	91.67	41.25	9.17	0.00	0.00	0.00	22.92	4.58	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.92	18.70	2.55	27.62	2.12	3.40	3.82	1.27	9.35	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	35.77	32.45	2.41	43.02	2.26	2.87	1.66	3.17	11.02	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	34.27	30.32	2.68	51.19	2.40	2.40	2.40	4.65	11.84	0.85
corpus callosum, adult, pool1	10042-101F6	110.89	24.77	14.59	3.87	1.88	1.44	3.54	1.44	2.76	0.77
cruciate ligament, donor2	10295-104G7	410.91	76.99	21.07	9.73	34.85	12.97	5.67	0.81	0.00	4.05
diaphragm, fetal, donor1	10069-101I6	390.85	40.13	19.26	4.82	12.84	8.83	4.82	7.22	2.41	2.41
diencephalon, adult	10193-103E4	276.71	17.04	12.96	5.28	5.04	4.08	6.24	0.24	4.32	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	5.97	2.53	0.00	0.00	0.23	0.69	1.61	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	195.15	107.70	14.10	9.23	1.28	2.56	5.39	6.15	1.54	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	485.05	54.64	19.98	13.24	12.52	7.94	6.50	5.54	3.13	1.69
ductus deferens, adult	10196-103E7	366.28	59.80	22.92	4.98	12.46	5.48	8.47	1.99	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	416.23	40.33	20.16	2.88	25.92	20.16	12.96	1.44	2.88	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	533.35	83.13	8.83	9.56	9.56	12.51	12.51	0.74	3.68	2.94
dura mater, adult, donor1	10041-101F5	273.36	49.55	26.92	9.75	4.79	4.79	8.18	2.81	2.81	1.82
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	188.32	27.98	2.22	14.66	11.55	6.44	1.33	4.66	2.66	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	282.29	63.19	3.58	10.32	8.60	7.59	2.58	5.45	1.86	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	314.47	32.06	6.78	7.40	1.85	0.62	9.25	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	253.67	36.33	8.48	6.66	5.45	3.33	6.36	1.82	2.72	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	296.71	35.81	7.72	12.04	2.16	0.62	6.79	1.85	1.85	0.31
embryonic pancreas cell line:2C6	10603-108E9	334.93	47.28	5.25	9.19	1.31	2.63	9.19	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	152.85	22.46	3.69	5.03	2.01	2.35	2.01	2.01	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1042.28	60.35	20.12	11.96	36.25	24.65	8.70	6.16	3.99	6.34
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	354.11	45.35	4.34	2.73	7.24	8.68	6.11	1.29	1.13	3.70
epidermoid carcinoma cell line:A431	10426-106D3	171.52	35.57	12.78	8.34	2.11	2.67	4.22	0.89	2.89	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	173.67	30.25	17.38	2.42	1.87	1.76	6.82	1.98	0.44	0.55
epididymis, adult	10197-103E8	256.41	67.40	17.79	7.12	10.05	9.00	4.40	2.51	2.09	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	488.41	23.06	4.08	3.02	12.24	11.89	2.31	1.24	1.24	2.13
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	320.10	27.53	4.33	1.57	3.54	2.75	0.79	0.79	1.18	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	608.07	53.73	37.61	3.67	11.93	16.77	6.42	2.62	1.57	4.32
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	507.26	41.43	38.88	3.05	7.48	12.60	5.51	2.36	0.98	2.85
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	671.28	54.22	43.02	3.92	12.32	17.03	6.27	3.14	1.57	4.59
esophagus, adult, pool1	10015-101C6	394.03	89.40	24.31	9.03	9.98	7.54	8.07	3.08	2.97	1.49
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	865.01	279.03	22.17	18.03	9.64	8.14	4.13	14.78	4.26	2.63
eye - muscle inferior rectus, donor1	10272-104E2	212.48	65.19	14.49	2.41	19.32	0.00	16.90	0.00	2.41	12.07
eye - muscle lateral, donor2	10298-104H1	189.38	29.46	4.21	4.21	10.52	8.42	2.10	2.10	2.10	2.10
eye - muscle medial, donor2	10299-104H2	247.04	44.65	8.93	7.44	10.42	1.49	7.44	4.46	0.00	1.49
eye - muscle superior, donor2	10297-104G9	276.31	48.15	10.32	5.73	19.49	10.32	8.03	1.15	1.15	2.29
eye - vitreous humor, donor1	10268-104D7	405.15	56.84	8.74	4.37	16.03	4.37	2.91	1.46	1.46	4.37
eye, fetal, donor1	10054-101G9	912.96	55.42	25.68	7.37	15.51	24.66	12.97	1.78	4.32	6.10
fibrosarcoma cell line:HT-1080	10758-110E2	396.60	17.82	9.49	3.46	11.41	6.41	6.92	1.03	0.64	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	391.50	45.11	12.35	9.97	8.55	4.04	7.83	3.56	0.47	1.19
frontal lobe, adult, pool1	10040-101F4	300.89	25.99	24.49	16.89	5.16	4.97	12.57	1.41	19.33	1.50
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	125.20	17.11	6.31	2.40	9.91	4.80	2.40	1.50	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	113.11	52.76	12.07	3.93	1.10	1.55	4.66	2.65	0.46	0.46
gall bladder, adult	10198-103E9	293.10	71.95	21.97	11.83	10.62	8.45	6.28	4.83	4.10	1.69
gamma delta positive T cells, donor1	11937-126A2	143.34	38.12	18.25	0.00	3.76	0.54	8.59	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	39.59	12.70	5.98	0.37	0.75	0.00	2.99	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	295.49	40.13	9.93	8.66	8.24	5.07	1.69	1.48	2.11	2.53
gastric adenocarcinoma cell line:MKN45	10612-108F9	355.30	45.84	23.02	6.19	5.22	3.87	11.99	2.32	0.58	1.16
gastric cancer cell line:AZ521	10549-107H9	611.88	93.78	16.07	15.74	7.54	8.85	7.38	11.48	2.79	1.97
gastric cancer cell line:GSS	10560-108A2	534.49	23.80	5.49	7.32	9.15	3.66	7.32	0.92	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	275.29	26.04	11.88	5.71	3.43	3.43	3.43	0.91	0.91	1.14
giant cell carcinoma cell line:LU65	10487-107B1	8.84	13.20	1.38	4.25	0.92	1.15	1.26	1.38	1.03	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	113.51	42.55	5.18	12.88	1.26	0.98	4.62	3.64	1.82	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	216.99	39.66	11.47	16.46	4.49	4.74	6.48	1.25	2.99	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	248.15	33.78	8.55	2.74	3.17	1.58	1.79	1.48	0.21	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	234.11	27.25	5.90	0.70	2.53	3.23	1.12	0.70	0.14	1.40
glioblastoma cell line:T98G	10485-107A8	295.80	91.72	9.38	5.19	4.97	5.74	3.20	2.87	1.21	0.77
glioma cell line:GI-1	10413-106B8	251.29	51.55	15.52	4.98	6.15	7.91	3.22	3.81	1.76	1.46
globus pallidus - adult, donor10196	10175-103C4	273.34	11.66	8.75	2.92	7.29	2.92	8.02	0.00	4.37	0.73
globus pallidus, adult, donor10252	10161-103A8	227.25	29.05	16.11	3.91	3.17	2.69	7.81	0.98	2.93	1.46
globus pallidus, adult, donor10258	10367-105F7	128.71	8.22	6.85	0.00	10.95	1.37	6.85	0.00	1.37	4.11
globus pallidus, newborn, donor10223	10364-105F4	314.42	23.98	6.93	4.80	15.45	8.53	8.53	2.66	1.60	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	46.50	19.58	0.00	0.00	0.00	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	26.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	443.51	36.80	9.60	4.48	5.44	5.44	3.84	2.88	1.28	1.92
hIPS +CCl2, biol_rep1	14383-156B9	546.35	27.09	13.31	2.75	11.94	9.18	10.10	0.46	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	538.65	24.69	14.18	1.83	9.60	5.03	7.77	0.46	1.83	1.37
hIPS +CCl2, biol_rep3	14385-156C2	543.61	15.46	6.44	0.64	9.66	8.37	8.37	0.00	1.29	0.64
hIPS, biol_rep1	14380-156B6	886.81	20.12	1.44	1.44	11.50	1.44	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	637.17	28.12	4.12	0.69	15.09	6.17	4.80	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	334.35	22.07	13.24	1.10	5.52	4.41	6.62	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	86.78	36.78	2.59	34.48	2.59	2.30	6.32	4.31	11.21	0.86
heart - mitral valve, adult	10205-103F7	339.93	67.57	16.74	10.76	5.08	5.38	3.29	4.48	2.39	2.39
heart - pulmonic valve, adult	10206-103F8	258.86	93.35	30.33	9.41	19.35	10.72	3.66	4.71	2.35	2.35
heart - tricuspid valve, adult	10207-103F9	421.32	122.40	23.31	24.98	8.33	9.99	5.00	9.16	5.00	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	321.39	40.20	13.06	3.47	6.12	7.96	8.98	3.47	2.24	3.26
heart, adult, diseased, donor1	10051-101G6	226.97	30.23	13.63	6.39	7.66	4.68	5.54	1.28	2.13	2.13
heart, adult, pool1	10016-101C7	184.67	45.08	9.20	4.60	1.15	0.46	2.99	2.30	2.07	0.69
heart, fetal, pool1	10046-101G1	498.10	100.11	39.12	12.22	4.31	6.26	11.81	4.00	2.98	2.05
hepatic mesenchymal tumor cell line:LI90	10778-110G4	265.33	24.99	9.56	12.03	6.48	1.54	8.64	1.54	5.24	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	1589.93	162.92	11.89	13.08	5.95	2.38	19.03	4.76	2.38	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	485.74	42.98	12.04	4.64	7.51	10.39	6.85	3.87	1.55	3.31
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	478.94	44.18	15.66	4.49	6.31	11.17	7.16	3.16	2.18	2.79
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	503.14	42.64	13.74	7.28	4.65	9.50	7.28	3.13	1.72	3.74
hepatoma cell line:Li-7	10484-107A7	400.71	34.14	8.45	4.11	6.45	7.01	3.89	1.67	1.45	1.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	120.10	17.39	7.14	3.82	3.12	1.51	9.45	1.51	0.20	0.40
hippocampus - adult, donor10196	10169-103B7	514.80	19.87	19.87	17.03	11.36	9.46	14.19	0.95	18.93	15.14
hippocampus, adult, donor10252	10153-102I9	492.90	39.80	25.72	7.76	10.61	6.53	17.35	3.06	18.16	4.69
hippocampus, adult, donor10258	10374-105G5	413.30	27.89	5.98	5.48	9.96	3.49	6.97	0.00	11.95	1.49
hippocampus, newborn, donor10223	10363-105F3	789.90	26.44	10.93	19.74	16.92	10.22	16.21	0.70	17.27	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	366.82	32.96	14.04	5.49	45.17	22.58	6.71	3.66	0.00	8.54
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	621.27	41.63	7.07	7.46	20.81	11.58	11.78	2.36	2.16	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	433.65	42.40	10.41	7.36	26.66	11.93	8.89	3.30	1.27	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	3359.50	68.79	29.88	43.42	166.90	84.58	20.86	10.15	12.41	6.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3514.77	119.29	21.69	63.52	240.39	145.11	26.60	18.07	14.20	13.43
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	2826.57	86.17	18.22	28.47	149.19	59.60	14.05	11.39	9.87	9.11
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	915.27	45.84	12.55	21.02	63.35	34.45	9.34	4.09	5.55	4.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1468.15	64.63	17.23	29.94	61.18	33.18	17.23	4.31	6.89	6.03
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1213.68	67.57	16.68	22.52	47.13	22.10	8.34	5.00	7.51	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1043.31	80.27	14.92	17.76	35.76	18.23	8.76	3.55	3.79	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1364.81	76.18	16.71	27.00	48.22	26.84	20.57	5.14	6.75	5.63
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	1026.79	65.98	12.12	13.47	22.22	12.12	8.75	2.69	2.69	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	465.54	31.92	10.64	7.20	20.34	12.05	10.95	2.50	1.10	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	509.47	28.99	13.76	4.91	40.29	22.11	13.76	1.47	1.97	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	235.64	22.69	13.96	6.98	42.76	12.22	1.75	1.75	0.87	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	3357.93	101.76	21.19	43.91	140.70	72.16	25.20	11.45	12.60	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3209.50	104.22	21.37	42.30	141.72	62.36	21.80	9.59	10.90	5.23
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1527.27	41.48	25.49	36.48	186.41	78.46	17.49	10.49	7.50	6.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1147.87	65.94	9.42	24.11	48.42	32.78	22.04	4.71	8.10	6.03
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1327.77	82.30	6.37	25.46	56.38	40.47	30.92	6.37	6.37	5.46
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1152.08	55.44	14.41	20.99	57.95	27.88	19.11	3.45	8.14	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	1577.98	66.63	14.37	20.74	45.56	27.76	22.21	4.74	6.04	4.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	1387.10	67.93	10.45	17.71	45.87	22.35	19.74	2.90	5.23	4.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	1497.01	57.69	16.74	18.53	52.01	31.98	16.44	2.69	4.18	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	660.28	47.66	12.19	9.42	29.19	16.63	9.79	4.06	4.25	4.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	726.33	37.09	12.55	10.56	37.94	15.12	13.12	2.00	1.71	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	444.24	30.62	16.33	9.80	37.56	15.11	8.57	3.27	2.04	4.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1881.17	78.16	20.07	29.22	88.37	66.54	15.84	4.93	7.04	7.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	2403.11	87.42	17.74	32.31	96.92	55.43	17.42	7.29	5.38	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	2016.36	81.40	18.46	31.78	100.17	56.29	13.62	9.99	8.47	5.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	993.91	61.54	9.31	21.72	27.92	23.79	16.03	5.17	4.65	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	1164.28	56.45	7.31	13.28	46.49	29.22	13.28	1.33	0.66	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	599.00	38.48	6.41	11.29	6.67	7.70	7.18	2.57	3.08	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	797.11	65.96	12.27	15.34	26.08	27.87	13.80	4.60	4.86	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	1246.39	71.94	6.82	14.39	40.13	39.38	18.17	4.54	5.30	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	869.04	52.42	13.78	13.11	37.30	23.86	8.74	5.04	3.70	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	717.27	40.09	12.08	9.42	27.29	16.18	10.14	3.38	2.42	4.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	478.64	26.74	10.25	8.02	36.99	18.27	9.36	1.78	2.67	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	549.76	40.00	11.71	8.78	30.73	17.56	5.37	2.93	1.95	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2778.98	91.69	20.17	36.06	112.47	65.71	14.06	11.00	7.95	7.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1398.89	130.13	55.31	84.58	367.62	97.60	9.76	16.27	16.27	45.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1275.45	55.93	31.44	27.80	227.36	85.71	4.96	5.63	9.27	12.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1277.94	61.84	9.30	22.44	42.14	31.20	13.68	4.93	5.47	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	910.50	36.91	11.58	17.01	33.29	20.27	13.03	2.90	3.62	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	803.56	43.77	11.03	14.23	40.93	24.56	10.68	2.14	5.69	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1211.28	54.90	9.55	13.13	38.19	32.22	10.74	7.16	4.77	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	1010.82	60.40	20.72	18.55	53.09	35.62	14.08	5.28	3.93	3.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	1102.63	47.68	12.12	16.97	40.68	23.17	12.93	2.16	5.12	2.69
immature langerhans cells, donor1	11904-125F5	445.55	116.96	13.80	8.48	9.44	8.23	7.51	1.94	4.36	1.70
immature langerhans cells, donor2	11905-125F6	414.29	111.69	10.30	19.80	5.54	11.09	15.05	3.96	4.75	8.71
insula, adult, pool1	10039-101F3	417.05	31.04	24.51	21.20	3.60	5.11	13.91	1.89	22.43	1.51
keratoacanthoma cell line:HKA-1	10791-110H8	46.50	13.98	2.93	4.23	0.00	0.65	4.23	0.65	2.93	0.65
kidney, adult, pool1	10017-101C8	483.31	66.38	24.63	7.41	8.41	9.01	5.21	3.40	1.80	2.50
kidney, fetal, pool1	10045-101F9	407.01	102.50	35.08	12.24	4.24	4.53	8.70	6.01	3.61	2.62
large cell lung carcinoma cell line:IA-LM	10509-107D5	236.32	60.36	20.02	6.11	4.83	4.26	12.36	3.27	1.99	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	98.70	28.75	4.42	1.94	2.07	1.80	2.90	1.38	0.55	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	335.80	47.71	7.71	10.83	3.85	2.94	4.04	2.75	1.65	1.65
left atrium, adult, donor1	10079-102A7	211.40	30.51	21.79	4.90	10.90	10.90	11.99	1.09	2.72	5.45
left ventricle, adult, donor1	10078-102A6	153.72	23.26	7.08	3.03	6.57	5.56	6.57	2.53	1.01	2.53
leiomyoblastoma cell line:G-402	10721-110A1	2003.65	65.39	16.69	10.40	16.69	11.77	9.85	3.56	3.01	4.92
leiomyoma cell line:10964C	10569-108B2	147.29	42.03	3.59	8.62	6.47	4.31	5.39	2.51	2.87	1.44
leiomyoma cell line:15242A	10570-108B3	161.41	50.54	2.17	9.24	5.98	3.26	3.26	2.72	1.09	1.09
leiomyoma cell line:15425	10571-108B4	273.41	59.49	6.07	14.57	8.74	12.63	3.40	4.13	3.16	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	247.63	31.75	12.70	0.00	6.35	0.00	6.35	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	500.82	65.87	10.46	11.50	8.36	4.18	6.27	6.27	1.05	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	137.30	26.92	5.55	5.19	1.89	1.89	8.38	2.13	1.30	0.83
liposarcoma cell line:KMLS-1	10782-110G8	406.77	50.92	11.87	3.59	8.28	4.84	4.22	2.50	0.47	2.03
liposarcoma cell line:SW 872	10726-110A6	785.98	47.64	12.18	3.41	9.63	6.82	6.46	1.83	0.97	3.05
liver, adult, pool1	10018-101C9	733.65	105.83	24.15	14.91	36.79	11.67	3.08	9.24	1.62	5.19
liver, fetal, pool1	10086-102B5	921.90	40.45	5.64	13.17	17.87	13.17	4.70	6.58	3.76	4.70
locus coeruleus - adult, donor10196	10182-103D2	142.76	31.06	11.81	4.67	3.35	1.46	3.94	2.19	1.46	1.02
locus coeruleus, adult, donor10252	10165-103B3	173.66	25.10	12.36	3.32	2.40	3.32	3.14	1.11	1.29	2.21
locus coeruleus, adult, donor10258	10375-105G6	66.87	12.41	6.49	1.41	9.87	3.67	2.26	0.56	0.85	0.00
locus coeruleus, newborn, donor10223	10362-105F2	141.33	23.13	34.49	7.15	17.67	10.52	2.52	1.26	2.10	2.52
lung adenocarcinoma cell line:A549	10499-107C4	447.43	28.09	12.87	2.77	4.29	3.60	4.57	2.77	0.83	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	536.36	101.34	26.20	8.27	2.76	1.38	13.10	3.45	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	198.65	30.32	5.93	6.06	2.50	2.37	13.31	2.64	1.05	0.53
lung, adult, pool1	10019-101D1	345.88	77.96	31.19	10.04	8.98	5.91	6.85	4.73	2.24	1.42
lung, fetal, donor1	10068-101I5	547.98	131.57	54.51	11.13	9.70	10.85	8.85	2.85	0.86	1.43
lung, right lower lobe, adult, donor1	10075-102A3	659.83	56.82	51.78	24.74	44.91	19.70	11.91	6.87	3.67	6.87
lymph node, adult, donor1	10077-102A5	163.78	19.41	6.63	4.73	10.89	8.05	9.94	2.84	0.47	2.37
lymphangiectasia cell line:DS-1	10727-110A7	160.00	30.90	6.58	3.95	2.41	4.60	9.42	2.85	0.88	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.94	4.98	0.45	2.26	0.15	0.15	0.15	0.75	0.30	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	142.72	28.03	8.49	3.40	3.40	1.70	0.00	1.70	1.70	1.70
mature adipocyte, donor1	12231-129F8	195.80	130.98	5.77	2.66	0.89	4.88	8.88	4.44	1.78	0.89
mature adipocyte, donor2	12232-129F9	180.96	112.90	7.47	3.94	6.02	3.11	7.06	5.81	1.04	2.70
mature adipocyte, donor3	12233-129G1	99.80	89.85	3.32	5.22	2.84	1.19	5.69	4.50	0.24	1.19
mature adipocyte, donor4	12234-129G2	145.56	123.71	7.11	3.42	3.95	2.63	7.11	5.00	0.79	2.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	538.23	55.75	41.46	5.48	9.05	5.48	18.58	3.34	2.62	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	373.38	12.41	28.20	18.05	16.92	7.90	13.54	2.26	16.92	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	341.88	31.82	39.17	14.34	7.91	4.97	13.06	2.39	20.05	3.13
medial frontal gyrus, adult, donor10258	10368-105F8	228.42	8.26	18.74	9.85	11.44	5.40	9.21	0.32	9.21	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	405.59	35.82	21.32	35.82	33.27	9.81	8.96	2.99	31.13	8.10
medial temporal gyrus - adult, donor10196	10183-103D3	330.92	19.07	33.92	18.06	19.74	24.81	17.38	0.84	13.67	4.39
medial temporal gyrus, adult, donor10252	10156-103A3	443.97	44.57	33.74	19.10	11.46	9.34	14.64	1.70	24.62	4.67
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	356.36	5.78	9.63	9.63	11.56	3.85	7.71	0.00	5.78	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	330.13	71.77	43.06	28.71	14.35	43.06	43.06	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	713.56	22.61	11.84	18.66	23.33	7.90	14.00	1.08	25.13	3.23
medulla oblongata - adult, donor10196	10174-103C3	136.93	18.82	20.12	0.65	4.54	4.54	6.49	0.00	2.60	1.95
medulla oblongata, adult, donor10252	10155-103A2	289.17	33.90	31.58	4.49	4.64	5.73	4.80	2.17	2.01	2.01
medulla oblongata, adult, pool1	10038-101F2	134.60	34.04	13.96	4.65	0.98	1.31	6.61	2.45	1.96	0.65
medulla oblongata, newborn, donor10223	10361-105F1	307.95	49.65	18.05	8.68	11.80	5.21	6.94	1.74	2.08	1.39
medulloblastoma cell line:D283 Med	10838-111E1	1756.68	20.81	34.54	6.20	28.78	23.69	19.71	1.77	1.55	5.09
medulloblastoma cell line:ONS-76	10759-110E3	249.93	16.75	5.14	1.96	2.08	1.59	6.85	0.86	0.49	0.12
melanoma cell line:COLO 679	10514-107E1	183.56	37.81	1.72	9.63	5.17	4.31	3.16	3.16	1.29	0.57
melanoma cell line:G-361	10465-106H6	87.14	90.40	2.44	11.94	11.13	9.50	2.17	4.07	4.34	1.36
meningioma cell line:HKBMM	10691-109F7	242.95	108.36	10.67	21.71	7.96	10.67	4.16	8.14	3.26	3.62
merkel cell carcinoma cell line:MKL-1	10843-111E6	540.15	22.91	20.27	5.29	24.67	7.05	16.74	1.76	2.64	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	1262.16	23.85	18.92	4.93	13.48	11.67	18.40	2.07	2.59	7.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	419.64	98.66	13.66	23.48	9.36	6.14	5.22	8.29	2.61	2.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	437.36	72.17	11.63	21.63	6.36	5.64	4.36	6.36	3.82	2.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	262.13	83.65	9.52	17.81	6.21	5.80	4.97	2.90	3.73	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	276.17	45.09	8.57	16.72	2.67	3.37	3.37	3.51	3.23	2.11
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	357.60	38.51	10.21	15.41	6.35	3.66	3.85	5.01	1.93	1.93
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	174.21	65.94	4.86	8.33	6.25	4.86	1.39	2.78	0.69	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	171.29	49.60	7.21	9.27	3.26	3.26	3.09	4.98	1.03	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	245.56	62.34	11.39	23.81	3.80	4.49	4.95	4.60	2.99	1.84
mesenchymal precursor cell - cardiac, donor3	11754-123G8	529.09	68.84	11.41	18.57	9.42	5.84	5.84	5.97	2.12	2.65
mesenchymal precursor cell - cardiac, donor4	11755-123G9	175.01	36.33	7.97	15.12	2.84	2.03	5.94	4.86	3.38	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	424.08	54.91	10.10	16.36	4.13	3.56	4.13	5.83	2.28	2.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	142.61	54.01	3.95	5.93	4.94	3.62	3.62	3.62	2.31	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	412.21	64.90	9.41	28.37	5.26	3.32	5.12	7.33	2.77	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	427.98	89.71	10.12	25.13	13.27	8.38	6.28	6.98	1.75	3.49
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	301.76	77.17	5.31	32.46	6.33	4.90	3.67	8.17	5.10	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	278.58	83.39	6.11	10.06	8.63	8.99	2.52	3.24	3.24	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	354.21	54.52	11.07	18.10	6.83	4.66	4.55	4.34	2.07	1.66
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	126.76	40.58	2.96	5.02	3.42	2.74	2.74	2.05	0.23	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	326.42	46.99	10.07	20.98	5.03	2.94	7.13	5.45	1.26	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	370.46	52.75	10.01	18.23	5.08	5.98	4.33	5.38	2.54	1.94
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	464.96	53.57	9.72	11.03	8.49	5.95	4.46	6.56	1.93	3.50
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	230.10	61.85	4.79	11.04	5.15	5.89	1.84	2.95	2.58	3.31
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	290.45	79.55	5.44	18.60	9.16	7.73	2.86	4.29	4.29	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	636.99	71.57	3.79	11.79	22.31	16.00	6.74	4.63	2.11	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	506.45	74.44	5.94	6.85	13.24	5.94	5.02	3.20	2.28	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	494.18	68.55	14.58	6.91	12.02	11.51	6.39	2.81	1.53	5.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	533.72	71.20	13.87	8.90	14.92	9.95	5.50	1.83	2.09	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	572.12	85.96	15.71	8.93	16.64	16.33	4.31	3.08	1.54	4.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	495.42	69.67	13.89	8.00	12.71	11.30	5.88	2.82	1.41	3.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	565.56	68.37	11.85	10.49	13.54	10.83	6.43	2.03	1.35	4.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	550.55	68.77	16.50	10.61	17.29	11.00	3.93	3.93	0.79	5.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	510.19	65.80	15.29	7.41	14.36	8.80	5.56	2.78	1.39	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	531.34	96.61	0.00	0.00	96.61	0.00	0.00	0.00	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	628.46	76.72	17.88	14.13	17.88	10.96	5.19	4.90	1.73	5.48
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	539.23	74.52	13.61	6.92	9.82	9.59	5.58	2.23	0.89	3.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	545.12	73.55	14.18	8.17	14.66	11.06	6.49	2.40	1.68	5.53
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	631.40	79.93	14.67	10.27	5.87	6.60	7.33	2.93	1.47	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	530.00	79.89	14.77	8.73	11.75	10.07	5.37	3.02	1.34	3.02
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	490.03	77.37	13.51	4.91	14.33	11.87	3.68	2.87	1.23	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	502.58	73.45	14.60	6.44	14.60	10.31	3.44	3.01	0.86	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	546.88	73.83	2.73	10.94	8.20	5.47	5.47	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	516.50	92.97	10.33	10.33	41.32	15.49	5.16	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	444.63	75.03	9.09	5.52	16.89	10.07	3.57	2.92	0.97	5.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	528.16	75.66	5.82	8.73	23.28	20.37	4.36	1.45	0.00	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	591.72	71.43	9.06	8.53	21.32	9.06	5.33	3.73	0.53	3.73
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	510.29	70.33	9.81	4.91	25.35	12.27	5.72	3.27	0.82	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	518.16	71.91	12.05	8.16	13.99	13.99	4.66	3.89	0.39	3.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	468.02	65.06	2.10	4.20	25.18	31.48	2.10	4.20	0.00	10.49
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	467.92	67.56	14.90	7.95	9.93	15.90	2.98	1.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	452.89	66.74	19.07	19.07	23.84	19.07	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	457.18	81.24	6.52	5.93	24.31	12.45	5.34	2.96	0.59	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	555.62	81.64	9.75	6.09	19.50	15.84	7.31	8.53	1.22	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	514.00	108.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	536.48	72.21	10.77	6.33	18.37	15.83	5.07	3.17	0.63	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	265.58	57.25	5.52	3.45	13.11	7.93	2.76	1.38	0.34	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	283.69	49.43	2.15	6.45	12.90	10.75	2.15	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	335.31	39.92	7.98	3.99	23.95	3.99	3.99	0.00	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	265.18	58.55	3.44	3.44	13.78	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	208.62	53.38	6.52	2.44	2.44	6.93	4.89	0.41	0.41	2.85
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	220.06	46.87	12.71	3.97	3.18	6.36	3.18	0.00	0.00	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	158.58	56.01	8.84	4.72	7.07	2.95	5.90	0.59	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	124.68	44.89	6.55	1.87	3.74	3.12	2.81	1.56	0.94	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	151.04	61.49	5.35	1.34	5.35	4.01	8.02	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	205.78	100.53	4.73	7.10	5.91	1.18	3.55	2.37	1.18	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	166.92	69.34	10.27	10.27	5.14	15.41	2.57	2.57	7.70	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	180.36	79.17	4.13	11.01	2.07	2.75	2.07	1.38	2.07	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	231.08	75.71	8.91	7.42	7.92	5.94	3.46	3.46	0.49	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	196.26	50.47	8.97	2.24	11.22	2.24	0.00	2.24	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	224.53	59.79	6.36	5.72	7.00	6.36	5.09	2.54	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	278.86	54.40	3.63	2.82	6.45	3.63	4.84	1.21	1.21	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	263.85	58.88	4.36	0.00	4.36	6.54	6.54	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	252.14	63.35	2.53	5.07	7.60	2.53	3.80	3.80	2.53	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	234.26	49.76	3.03	2.43	8.50	3.64	3.03	1.21	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	225.95	54.23	0.00	4.52	4.52	4.52	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	273.46	41.18	0.82	4.12	8.24	8.24	3.29	1.65	1.65	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	213.11	55.96	8.73	4.37	4.96	2.18	2.58	2.78	1.39	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	231.69	75.93	3.89	8.44	6.81	7.79	2.92	1.30	0.65	2.27
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	289.29	75.38	6.11	8.15	5.09	11.20	2.04	4.07	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	318.77	70.41	6.19	3.87	1.55	0.77	2.32	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	613.76	56.70	17.48	10.87	8.98	4.49	12.52	5.91	3.54	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	156.61	24.56	6.02	3.24	2.78	2.32	1.16	1.62	1.16	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	346.16	51.28	4.27	0.00	25.64	0.00	8.55	4.27	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	116.62	13.25	8.01	1.34	11.61	6.27	1.34	1.13	0.51	2.57
mesothelioma cell line:Mero-25	10850-111F4	807.96	37.67	16.57	9.31	16.34	12.71	6.81	1.59	2.04	4.09
mesothelioma cell line:Mero-41	10851-111F5	375.51	108.55	13.69	10.51	12.96	7.58	4.16	4.89	2.93	1.96
mesothelioma cell line:Mero-48a	10852-111F6	493.35	45.61	11.51	3.99	11.07	9.52	5.54	2.88	1.77	2.21
mesothelioma cell line:Mero-82	10853-111F7	675.41	84.10	18.13	8.41	22.60	13.67	5.26	4.47	1.31	3.42
mesothelioma cell line:Mero-83	10854-111F8	767.01	26.38	13.28	2.38	17.70	12.77	3.57	1.36	0.85	2.72
mesothelioma cell line:Mero-84	10855-111F9	835.17	39.94	15.92	3.79	17.44	17.95	4.04	1.77	1.52	4.55
mesothelioma cell line:Mero-95	10856-111G1	494.42	51.97	9.73	2.07	13.46	10.35	3.93	2.48	1.66	2.07
mesothelioma cell line:NCI-H2052	10847-111F1	413.62	79.51	11.43	9.44	11.26	7.29	2.98	3.48	1.99	2.32
mesothelioma cell line:NCI-H226	10846-111E9	257.91	93.03	9.41	5.07	8.14	5.97	4.89	3.80	0.54	1.99
mesothelioma cell line:NCI-H2452	10848-111F2	765.63	110.18	16.06	7.35	19.30	19.13	4.10	3.59	2.56	4.95
mesothelioma cell line:NCI-H28	10845-111E8	293.14	40.21	12.72	3.31	7.38	6.11	7.63	2.54	0.76	1.53
mesothelioma cell line:No36	10857-111G2	489.63	51.21	20.55	2.28	16.31	10.76	6.52	0.65	1.63	3.26
mesothelioma cell line:ONE58	10858-111G3	386.11	65.57	5.96	5.69	11.38	7.32	3.79	1.35	1.35	1.08
migratory langerhans cells, donor1	11901-125F2	606.67	75.43	6.33	4.80	9.40	9.79	12.86	4.41	2.49	6.14
migratory langerhans cells, donor2	11902-125F3	564.66	75.22	4.40	6.35	7.82	6.84	8.67	2.20	2.20	2.32
migratory langerhans cells, donor3	11903-125F4	461.98	70.36	7.00	4.13	8.79	5.74	12.20	2.69	1.97	3.77
mixed mullerian tumor cell line:HTMMT	10689-109F5	361.74	60.40	9.79	3.92	32.65	18.61	3.92	2.61	1.96	3.92
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	194.56	33.91	18.65	5.09	10.60	8.90	23.95	1.70	2.33	2.33
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	172.77	18.20	6.68	1.84	1.15	1.61	6.22	0.46	0.92	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	61.27	10.09	1.33	24.36	3.23	2.09	5.33	1.14	8.18	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	124.00	12.20	4.44	1.85	2.96	0.92	2.77	1.11	0.74	1.11
myeloma cell line:PCM6	10474-106I6	51.59	27.67	5.93	0.99	1.58	0.99	2.97	1.38	0.40	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	1219.02	56.82	21.31	6.59	7.10	5.58	8.62	4.57	2.54	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	319.12	54.72	27.26	5.49	5.88	3.53	7.06	1.57	2.16	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	96.05	38.89	11.81	5.24	1.67	1.23	3.68	2.56	0.89	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	84.57	34.20	12.21	4.12	1.18	1.40	2.21	1.47	1.18	0.51
nasal epithelial cells, donor2	12227-129F4	516.66	40.30	8.83	8.83	4.97	3.31	9.38	1.66	3.31	2.21
neuroblastoma cell line:CHP-134	10508-107D4	756.90	36.81	20.48	4.14	10.35	6.67	14.49	2.99	2.76	2.99
neuroblastoma cell line:NB-1	10539-107G8	1041.69	103.65	47.89	48.64	16.46	12.53	20.95	6.92	16.65	5.43
neuroblastoma cell line:NBsusSR	10607-108F4	376.01	16.87	8.22	2.32	6.75	5.06	13.50	0.63	1.05	2.53
neuroblastoma cell line:NH-12	10555-107I6	726.40	75.10	13.04	8.01	7.83	6.89	16.03	2.05	5.59	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	670.87	5.22	10.44	0.71	14.23	12.81	7.83	0.00	0.24	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1995.60	12.35	26.92	8.39	23.76	25.34	10.61	1.74	5.86	5.07
neuroectodermal tumor cell line:TASK1	10774-110F9	371.32	7.04	6.04	0.81	8.45	6.84	4.83	0.00	0.60	2.82
neuroepithelioma cell line:SK-N-MC	10728-110A8	807.42	6.99	5.09	0.00	8.90	2.54	14.62	0.00	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	932.65	52.43	9.58	7.19	13.84	9.32	6.65	2.66	2.93	3.73
neutrophil PMN, donor1	12133-128D9	89.25	0.00	0.00	0.00	0.00	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	28.41	0.00	0.00	0.00	0.00	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	53.78	5.92	0.00	1.35	0.34	0.68	3.55	0.17	0.34	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1452.92	70.44	36.02	6.40	14.41	8.01	14.41	4.00	3.20	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	514.25	51.30	8.98	6.73	24.69	12.82	5.13	3.21	1.28	4.17
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	378.64	52.03	7.09	4.73	7.88	9.20	2.63	1.58	1.58	2.89
nucleus accumbens, adult, pool1	10037-101F1	405.52	25.87	25.31	13.50	3.28	5.25	11.90	1.50	16.22	2.53
occipital cortex - adult, donor10196	10172-103C1	331.72	24.72	45.33	20.60	6.18	12.36	4.12	0.00	14.42	0.00
occipital cortex, adult, donor10252	10163-103B1	387.52	45.62	36.77	15.30	8.32	8.59	11.81	2.95	23.88	3.22
occipital cortex, newborn, donor10223	10355-105E4	768.29	30.21	10.19	25.48	20.02	8.01	18.93	1.09	36.39	0.73
occipital lobe, adult, donor1	10076-102A4	343.48	24.40	18.11	29.65	12.86	14.69	19.42	1.31	24.67	5.77
occipital lobe, fetal, donor1	10073-102A1	1911.64	34.33	38.19	13.73	79.38	83.25	81.10	1.29	12.87	8.58
occipital pole, adult, pool1	10036-101E9	320.49	32.80	35.24	21.92	2.52	3.94	12.69	1.50	27.67	1.58
olfactory region, adult	10195-103E6	311.80	28.28	15.09	11.65	10.13	9.93	13.56	1.15	16.24	4.20
optic nerve, donor1	10277-104E7	154.08	40.02	8.00	8.00	10.01	2.00	8.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	668.64	52.85	41.69	12.76	9.34	8.54	6.04	3.99	1.82	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	186.16	45.20	9.48	2.89	3.02	2.47	8.38	0.96	2.20	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	206.24	29.63	10.84	5.25	5.93	6.10	2.88	0.85	1.69	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	129.14	79.01	12.01	19.29	4.16	3.23	3.58	3.81	4.85	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	598.52	87.31	12.93	15.29	12.35	4.41	10.29	4.70	2.94	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	171.92	52.32	6.54	10.28	0.00	1.87	0.00	6.54	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	458.90	47.29	22.05	4.45	8.91	6.36	5.94	1.91	2.33	1.91
ovary, adult, pool1	10020-101D2	644.13	116.26	128.41	20.88	18.61	13.63	9.78	7.16	4.11	3.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	446.75	15.22	8.98	3.30	7.33	6.78	5.87	0.92	1.28	1.28
pancreas, adult, donor1	10049-101G4	116.64	26.34	5.64	3.76	0.94	1.88	2.82	0.94	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	268.07	39.69	2.52	5.03	8.11	5.03	3.63	3.91	1.12	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	347.52	74.96	6.64	7.33	13.97	13.46	3.58	4.60	1.02	5.11
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	88.09	23.35	8.44	5.80	1.82	2.32	2.65	1.66	1.49	0.17
paracentral gyrus, adult, pool1	10035-101E8	271.36	29.74	25.08	16.38	3.48	4.03	8.79	1.83	23.16	1.37
parietal cortex, adult, donor10258	10373-105G4	919.71	15.41	16.15	10.28	11.74	3.67	12.48	0.00	16.15	2.20
parietal lobe - adult, donor10196	10171-103B9	251.11	13.17	19.75	10.35	16.93	8.46	8.46	1.88	17.87	8.46
parietal lobe, adult, donor10252	10157-103A4	335.77	38.77	36.20	18.24	6.84	5.13	10.83	1.43	20.81	3.42
parietal lobe, adult, pool1	10034-101E7	269.73	28.82	25.55	18.15	3.35	3.61	10.13	2.20	20.18	1.67
parietal lobe, fetal, donor1	10072-101I9	1873.72	51.40	36.85	9.70	135.78	86.32	64.98	1.94	9.70	15.52
parietal lobe, newborn, donor10223	10356-105E5	645.28	22.81	17.95	26.92	26.54	12.34	12.34	2.24	24.67	3.36
parotid gland, adult	10199-103F1	193.02	64.75	14.18	4.32	4.32	0.62	12.33	2.47	1.23	0.62
penis, adult	10200-103F2	357.18	96.68	34.38	15.04	23.63	12.35	11.82	3.22	5.91	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	297.31	4.28	13.76	2.79	6.14	2.42	4.09	0.19	0.93	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	202.95	26.52	6.41	4.66	3.93	3.35	5.25	1.17	0.29	1.60
pineal gland - adult, donor10196	10179-103C8	991.41	67.08	52.89	30.96	20.64	10.32	15.48	1.29	16.77	8.39
pineal gland, adult, donor10252	10160-103A7	961.16	74.03	204.31	45.01	31.98	14.21	21.32	6.51	15.40	7.11
pineal gland, adult, donor10258	10377-105G8	675.99	42.01	56.44	25.08	36.37	16.93	8.78	6.90	11.91	3.76
pituitary gland - adult, donor10196	10180-103C9	207.42	22.26	16.19	8.09	10.12	6.07	9.11	1.01	6.07	2.02
pituitary gland, adult, donor10252	10162-103A9	185.54	30.75	48.47	6.78	7.30	3.65	6.25	2.08	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	101.30	14.47	11.92	3.40	11.07	4.26	2.55	0.85	3.40	0.85
placenta, adult, pool1	10021-101D3	186.84	47.09	6.24	3.33	3.44	3.44	3.55	2.80	0.97	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	37.21	7.28	2.91	2.25	0.66	1.06	4.24	0.79	1.32	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	448.09	56.50	17.74	3.27	7.94	6.85	3.74	2.65	0.47	2.18
pons, adult, pool1	10033-101E6	128.58	30.21	18.42	5.08	1.46	2.07	5.51	2.75	2.75	0.60
postcentral gyrus, adult, pool1	10032-101E5	304.33	28.51	25.98	20.22	2.88	6.63	10.46	1.57	25.89	2.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	2.09	0.00	0.00	0.00	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	274.43	31.61	8.59	3.50	6.41	7.28	4.52	2.04	1.31	2.04
prostate cancer cell line:PC-3	10439-106E7	336.50	38.48	11.62	2.72	5.81	6.35	4.36	2.90	1.63	1.27
prostate, adult, pool1	10022-101D4	545.78	85.70	39.90	8.34	9.43	7.71	8.25	4.63	2.63	1.09
putamen, adult, donor10196	10176-103C5	846.29	26.20	30.22	6.14	12.98	15.82	22.66	2.12	15.34	6.14
putamen, adult, donor10252	10152-102I8	488.22	41.18	9.80	5.88	9.80	5.88	9.80	5.88	9.80	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	586.84	22.95	6.56	1.09	14.21	3.28	6.56	0.00	3.28	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	607.65	17.15	28.27	3.87	7.73	5.56	14.26	1.21	13.53	1.69
putamen, newborn, donor10223	10365-105F5	212.90	11.99	18.74	6.75	16.49	9.00	6.75	0.75	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	174.85	56.73	16.58	5.82	1.45	1.16	3.78	4.07	1.16	0.58
rectum, fetal, donor1	10067-101I4	855.46	75.11	22.26	4.17	29.21	18.08	29.21	1.39	5.56	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	194.61	54.70	9.75	4.88	2.97	2.54	5.51	3.18	0.85	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	102.31	27.75	7.87	2.90	5.80	5.38	9.53	0.00	0.41	0.83
retina, adult, pool1	10030-101E3	337.56	53.87	40.85	9.84	4.37	5.47	10.34	4.27	2.68	2.19
retinoblastoma cell line:Y79	10475-106I7	1442.16	15.59	42.35	4.16	25.72	30.14	9.87	1.04	2.34	7.27
rhabdomyosarcoma cell line:KYM-1	10787-110H4	1075.31	69.71	17.95	5.16	13.03	7.99	10.70	3.07	2.70	4.18
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	737.59	72.55	35.99	5.34	7.31	5.34	12.94	3.94	3.09	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	503.97	55.32	7.58	8.34	6.06	2.27	6.82	2.27	0.76	0.76
salivary acinar cells, donor1	11771-123I7	309.31	45.32	13.11	11.98	8.58	4.86	7.45	3.08	3.40	1.29
salivary acinar cells, donor2	11772-123I8	295.34	35.80	13.36	10.19	9.91	6.75	9.36	1.65	2.62	2.34
salivary acinar cells, donor3	11773-123I9	370.75	26.48	11.25	3.97	1.32	0.66	7.94	0.00	1.32	2.65
salivary gland, adult, pool1	10093-102C3	137.84	65.20	14.87	6.86	0.57	2.86	8.58	1.14	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	115.84	32.38	11.63	14.33	3.37	3.46	3.63	3.46	3.63	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	107.80	24.92	11.52	11.99	5.64	4.47	3.53	3.41	2.94	1.06
seminal vesicle, adult	10201-103F3	317.44	63.49	20.63	5.82	13.23	12.17	4.23	1.59	4.76	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	236.12	109.80	15.30	11.17	8.75	7.53	5.59	2.67	2.67	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	284.60	19.88	5.28	3.52	6.04	5.79	1.26	1.01	0.75	2.77
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	287.01	63.22	7.02	8.03	16.06	8.03	3.01	3.01	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	250.37	38.55	5.64	3.76	5.10	2.96	5.51	2.15	0.81	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	163.58	46.97	10.39	7.52	1.66	3.09	6.85	1.44	0.88	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	310.18	114.45	15.61	13.42	5.29	5.55	8.39	3.74	2.58	1.94
skeletal muscle - soleus muscle, donor1	10282-104F3	59.58	18.44	1.42	0.00	2.84	3.55	2.84	2.13	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	99.91	43.90	8.40	4.20	5.88	2.40	2.28	1.44	0.60	0.48
skeletal muscle, fetal, donor1	10066-101I3	361.81	45.23	17.09	6.03	25.13	22.11	18.09	1.01	4.02	4.02
skin, adult, donor1	10074-102A2	393.54	74.64	13.57	6.79	27.14	13.57	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	298.57	30.30	22.72	9.47	11.99	32.19	9.47	0.63	2.52	7.57
small cell cervical cancer cell line:HCSC-1	10800-110I8	2105.20	82.71	36.69	9.01	42.69	24.35	19.01	3.00	3.00	7.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1521.18	31.52	105.59	8.51	31.84	34.36	21.43	3.47	4.10	7.88
small cell lung carcinoma cell line:DMS 144	10841-111E4	331.33	16.00	5.40	6.17	6.75	7.71	12.14	2.12	4.24	2.51
small cell lung carcinoma cell line:LK-2	10541-107H1	491.51	110.60	25.55	12.03	5.93	6.92	22.42	7.91	4.29	2.47
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1415.48	29.60	25.58	5.95	22.84	12.55	31.20	3.38	3.22	4.50
small cell lung carcinoma cell line:WA-hT	10562-108A4	172.59	11.55	6.54	3.05	3.49	2.18	5.01	0.44	0.65	0.44
small intestine, adult, pool1	10024-101D6	221.21	48.73	12.54	5.26	8.48	5.26	3.58	3.22	0.84	1.31
small intestine, fetal, donor1	10064-101I1	369.04	32.19	14.74	4.42	17.94	19.41	13.02	0.98	0.98	2.70
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	68.22	64.11	3.08	4.62	6.67	3.08	6.67	1.54	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	581.52	67.46	27.65	14.47	13.44	10.86	13.44	5.43	6.46	4.65
somatostatinoma cell line:QGP-1	10781-110G7	918.51	75.85	37.52	10.72	8.04	4.56	45.30	3.48	2.41	2.41
spinal cord - adult, donor10196	10181-103D1	156.00	22.71	22.02	2.06	8.49	4.13	5.51	0.69	1.61	2.98
spinal cord, adult, donor10252	10159-103A6	276.78	29.57	28.78	1.97	8.67	4.34	5.91	1.58	1.58	3.15
spinal cord, adult, donor10258	10369-105F9	61.57	10.38	4.84	2.77	2.77	5.53	3.46	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	545.80	68.91	25.00	10.98	20.73	20.12	14.03	3.66	5.49	8.54
spinal cord, newborn, donor10223	10359-105E8	153.84	25.26	16.53	5.51	12.86	2.76	0.92	4.13	2.30	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	455.08	59.44	10.75	17.47	6.27	6.57	6.87	3.14	4.63	1.94
spleen, adult, pool1	10025-101D7	153.09	52.53	10.57	5.51	4.85	4.30	3.08	3.63	0.77	0.88
spleen, fetal, pool1	10044-101F8	183.86	59.67	11.84	10.25	1.43	2.22	5.16	3.58	2.22	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	43.37	7.14	5.69	2.07	0.41	1.24	4.55	0.93	0.62	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	145.63	28.10	10.44	2.47	3.99	2.47	2.47	0.19	0.95	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	322.19	74.08	13.28	1.75	9.44	14.33	11.18	2.45	1.05	3.84
squamous cell carcinoma cell line:T3M-5	10616-108G4	290.85	39.87	15.64	11.34	3.13	1.56	6.25	2.74	1.95	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.11	16.66	1.58	2.59	0.90	1.01	1.58	0.90	0.34	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	482.91	28.80	7.62	3.39	10.17	11.44	5.08	1.69	1.27	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	434.92	76.58	6.35	7.19	5.08	2.54	3.81	8.88	2.96	2.96
stomach, fetal, donor1	10062-101H8	607.68	44.85	4.27	3.20	3.20	4.27	24.56	1.07	3.20	2.14
submaxillary gland, adult	10202-103F4	125.33	41.59	6.27	3.99	4.56	3.42	3.42	1.71	2.28	6.27
substantia nigra - adult, donor10196	10178-103C7	325.64	0.00	0.00	0.00	217.10	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	133.97	24.30	8.93	2.91	4.78	3.12	1.25	1.04	1.04	1.04
substantia nigra, adult, donor10258	10371-105G2	121.04	15.00	5.69	1.03	3.10	2.59	3.62	0.00	2.07	0.00
substantia nigra, newborn, donor10223	10358-105E7	226.10	18.37	9.19	4.24	14.13	4.24	2.83	0.00	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1172.92	33.01	17.65	2.06	17.42	17.42	9.86	2.52	1.83	4.13
temporal lobe, adult, pool1	10031-101E4	409.44	38.23	25.94	26.28	5.51	7.71	15.60	1.61	28.99	3.56
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1803.46	28.49	32.76	10.68	65.53	83.34	70.51	2.14	15.67	17.81
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	1691.34	37.36	23.74	14.94	32.97	42.20	29.89	4.83	10.99	18.90
tenocyte, donor1	11763-123H8	698.55	78.90	10.12	9.43	17.80	17.46	5.24	2.09	0.70	5.59
tenocyte, donor2	11765-123I1	375.40	75.54	9.92	4.20	8.01	4.96	6.49	0.76	1.91	1.14
tenocyte, donor3	11768-123I4	409.96	120.10	10.01	11.86	8.15	8.90	4.82	6.30	1.48	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	996.48	47.08	6.97	9.01	23.28	13.60	7.99	3.91	3.40	6.97
teratocarcinoma cell line:NCR-G1	10798-110I6	3418.39	81.54	116.69	25.90	96.34	61.35	39.92	6.17	9.25	16.49
teratocarcinoma cell line:PA-1	10807-111A6	830.06	47.89	10.69	8.06	17.20	11.16	8.52	1.86	1.70	3.87
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	793.80	111.33	6.35	10.66	15.74	12.95	14.09	5.46	3.30	4.06
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	830.47	74.88	21.56	5.67	7.56	6.43	9.83	3.40	3.40	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	339.62	154.65	7.20	8.18	5.13	5.02	5.67	5.13	1.20	2.07
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	832.50	55.04	3.91	11.40	26.06	19.22	12.38	4.56	1.63	4.89
testis, adult, pool1	10026-101D8	216.36	78.17	41.45	7.84	14.50	7.09	6.23	5.15	1.40	1.50
testis, adult, pool2	10096-102C6	304.03	33.38	18.95	1.80	4.06	7.22	4.51	0.90	1.80	0.45
thalamus - adult, donor10196	10168-103B6	110.40	20.98	13.25	1.10	5.52	4.42	1.10	0.00	1.10	1.10
thalamus, adult, donor10252	10154-103A1	222.86	28.60	18.60	2.66	2.97	3.59	5.47	0.78	2.97	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	201.69	20.02	7.70	0.00	1.54	3.08	1.54	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	92.89	12.68	5.60	2.14	10.05	4.78	4.78	0.49	0.99	0.66
thalamus, newborn, donor10223	10366-105F6	196.18	59.83	24.74	18.41	18.99	11.51	4.60	1.15	8.63	2.88
throat, adult	10209-103G2	156.54	39.20	11.98	5.49	2.00	3.50	3.50	1.75	1.00	1.25
throat, fetal, donor1	10061-101H7	483.87	50.89	32.30	7.31	17.37	16.76	12.49	3.96	3.35	3.35
thymic carcinoma cell line:Ty-82	10803-111A2	464.63	10.73	13.12	0.40	10.14	6.16	12.92	0.60	1.19	1.79
thymus, adult, pool1	10027-101D9	119.30	10.14	5.67	2.49	4.27	2.78	6.96	0.89	0.60	0.99
thymus, fetal, pool1	10043-101F7	112.32	17.98	6.86	1.97	1.45	1.97	3.64	1.04	0.62	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	192.00	44.81	10.37	3.72	8.64	5.85	3.99	2.79	0.93	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	354.67	25.70	9.50	2.37	6.84	4.75	5.03	1.40	0.56	1.82
thyroid, adult, pool1	10028-101E1	320.81	63.08	28.09	9.42	6.44	6.07	5.88	3.55	2.43	2.05
thyroid, fetal, donor1	10060-101H6	661.53	38.49	32.17	4.48	35.59	16.87	13.45	1.05	3.43	5.01
tongue epidermis (fungiform papillae), donor1	10288-104F9	221.73	70.83	12.32	3.08	12.32	9.24	12.32	9.24	0.00	9.24
tongue, adult	10203-103F5	243.04	70.47	15.35	8.84	6.05	6.51	10.93	1.63	2.56	1.86
tongue, fetal, donor1	10059-101H5	522.57	42.96	18.52	6.70	14.58	16.95	13.40	0.39	1.97	3.55
tonsil, adult, pool1	10047-101G2	142.65	33.76	15.73	3.01	1.20	1.30	5.31	1.20	1.60	0.60
trachea, adult, pool1	10029-101E2	210.14	60.04	16.69	7.36	3.76	4.34	4.74	3.19	1.88	0.57
trachea, fetal, donor1	10058-101H4	397.39	52.70	17.70	11.16	17.70	12.69	7.69	1.92	2.69	4.23
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	429.38	82.19	6.02	19.84	8.50	7.79	6.02	4.25	4.25	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	43.06	14.59	4.76	2.94	0.71	0.30	1.62	1.11	0.51	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	555.93	52.33	23.50	7.05	23.35	17.86	5.64	4.39	1.88	1.57
tridermal teratoma cell line:HGRT	10694-109G1	1006.44	85.61	7.61	11.42	11.42	3.81	13.32	5.71	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	433.58	130.45	12.11	10.07	8.55	5.59	7.96	5.16	2.54	2.29
umbilical cord, fetal, donor1	10057-101H3	367.22	25.04	8.35	10.43	22.95	18.78	8.35	2.09	6.26	6.26
uterus, adult, pool1	10100-102D1	634.57	140.26	56.65	18.94	11.09	9.90	7.00	6.31	2.39	2.22
uterus, fetal, donor1	10055-101H1	760.73	81.91	19.45	7.68	16.89	21.50	5.12	4.61	4.10	5.12
vagina, adult	10204-103F6	753.47	112.44	48.46	17.45	7.11	6.46	7.11	5.17	1.29	0.00
vein, adult	10191-103E2	196.18	68.39	13.37	8.99	5.70	6.14	6.36	2.85	1.53	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	93.46	8.28	8.28	4.81	2.14	1.34	7.74	0.53	1.87	1.34